Next Article in Journal
A Risk Correlative Model for Sleep Disorders in Chinese Older Adults Based on Blood Micronutrient Levels: A Matched Case-Control Study
Previous Article in Journal
Orthorexia as an Eating Disorder Spectrum—A Review of the Literature
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Dietary Polyphenols as Anti-Aging Agents: Targeting the Hallmarks of Aging

1
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
2
Nutrilite Health Institute, Amway (Shanghai) Innovation and Science Co., Ltd., Shanghai 201203, China
3
Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
*
Authors to whom correspondence should be addressed.
Nutrients 2024, 16(19), 3305; https://doi.org/10.3390/nu16193305
Submission received: 23 August 2024 / Revised: 20 September 2024 / Accepted: 27 September 2024 / Published: 29 September 2024
(This article belongs to the Section Phytochemicals and Human Health)

Abstract

:
Background: Aging is a natural biological process influenced by multiple factors and is a significant contributor to various chronic diseases. Slowing down the aging process and extending health span have been pursuits of the scientific field. Methods: Examination of the effects of dietary polyphenols on hallmarks of aging such as genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. Results: Polyphenols, abundant in nature, exhibit numerous biological activities, including antioxidant effects, free radical scavenging, neuroprotection, and anti-aging properties. These compounds are generally safe and effective in potentially slowing aging and preventing age-related disorders. Conclusions: The review encourages the development of novel therapeutic strategies using dietary polyphenols to create holistic anti-aging therapies and nutritional supplements.

Graphical Abstract

1. Introduction

Based on data from the World Health Organization (WHO Fact Sheet) and the World Bank (World Bank Data), the global population aged 65 and older was 727 million, constituting 9.3% of the total population in 2022. In China specifically, China’s population aged 65 and older accounted for 13.5% in 2020, an increase of 4.6 percentage points from 8.9% in 2010, and the elderly population is growing at a rate of 5% per year [1]. A country or region is deemed to enter an aging society when the proportion of the population aged 60 and older reaches 10% or that of the population aged 65 and older reaches 7%. Although it is controversial whether aging is an unavoidable degradative biological process, aging increases the risks of diseases and death, including metabolic disorders, cancer, and neurodegeneration [2]. Aging and age-related diseases significantly contribute to the health and financial burden worldwide as the increased elderly population.
Aging is complex, multifaceted, and influenced by genetic, environmental, and lifestyle factors [3]. In 2023, C López-Otín’s group expanded the original 9 hallmarks of aging to 12, providing a more comprehensive framework for anti-aging studies [4,5]. Currently, the most promising geroprotectors are targeting these hallmarks [6], such as genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. For example, metformin is primarily known as an anti-diabetic drug. However, studies have shown that low-dose metformin can activate the AMPK pathway through the lysosomal pathway and exert a life-extending effect [7]. Nicotinamide mononucleotide (NMN), the precursor of NAD+, is evidenced by studies that show its role in maintaining high NAD+ content and exerting life-extending effects by activating Silent information regulator 1 (SIRT1), enhancing mitochondrial function and reducing oxidative stress [8]. Quercetin is a flavonoid mainly present in onions. The combination of quercetin and dasatinib has been proven to reduce intestinal senescence and inflammation in the elderly and improve health by ameliorating microbial dysbiosis [9]. Oral administration of spermidine, a natural polyamine, has been evidenced to delay brain aging by regulating the level of autophagy proteins and preventing apoptosis and inflammatory responses [10]. These findings indicate that targeting the hallmarks of aging is promising for alleviating and reversing aging.
Polyphenols, a primary group of phytochemicals found in plant-based foods, are garnering increasing attention for their anti-aging effects. Numerous studies have indicated that polyphenols possess a range of biological activities, including anti-inflammatory effects, promotion of cellular repair, and antioxidant capability [11,12]. Free radicals are unstable molecules that cause oxidative stress, leading to cellular damage and inflammation and ultimately contributing to aging. Polyphenols, acting as powerful scavengers, protect cells from oxidative stress, reducing the risk of age-related diseases such as heart diseases [13], cancer [14], and neurodegenerative diseases (NDs) [15]. Beyond their antioxidative prowess, polyphenols can also regulate immune function, inflammatory response, and oxidative stress and improve the resistance to diseases including systemic lupus erythematosus [16], rheumatoid arthritis [17], and multiple sclerosis [18]. In the aspect of the nervous system, polyphenols have potential protective effects on cognitive functions and alleviate NDs through enhancement of mitochondrial function, prevention of cellular damage, and proper functioning of the DNA repair pathway [19]. At the same time, polyphenols also play an important role in regulating metabolic processes, such as improving blood glucose and blood lipid levels [20]. For example, polyphenol-rich strawberry juice has hypoglycemic and hypolipidemic effects on streptozotocin-induced diabetic rats by restoring carbohydrate metabolism enzymes and antioxidant enzyme activities to the normal level and reducing lipid peroxidation and proinflammatory cytokines [21]. Overall, polyphenols from natural products have many benefits targeting the anti-aging process on various organs and tissues, such as the brain, muscle, skin, heart, liver, and intestine (Figure 1).
This review synthesizes the anti-aging properties of different classes of polyphenols, emphasizing the targeting on the hallmarks of aging, aiming to offer strategies for postponing the aging process and extending good health.

2. Biological Activities of Polyphenols

Polyphenols are a class of secondary metabolites widely found in plants with two or more phenolic hydroxyl groups. Polyphenols are particularly abundant in fruits, vegetables, tea, and red wine. Depending on their chemical structure, polyphenols can be classified into flavonoids, phenolic acids, stilbenes, lignans, and other polyphenols. Flavonoids possess functions such as antioxidation [22] and anti-inflammation [23]. Anthocyanins have the ability to be antioxidative and are beneficial to aspects such as vision [24]. Stilbenes have a certain anti-cancer effect [25]. Lignans have an impact on hormone regulation [26]. Among polyphenols, flavonoids are probably the most well-researched and well-known group. According to their composition, flavonoids can be further classified into subclasses such as flavones, flavanols (flavan-3-ols), isoflavones, flavanones, anthocyanins, and chalcone [27]. Flavonoids are valued for their strong antioxidant activity, which is promising to slow the aging process by scavenging free radicals and reactive oxygen species (ROS) and alleviating cellular damage caused by oxidative stress. It can also increase blood circulation, lower cholesterol, and lower cardiovascular disease risk [28,29]. In recent years, many different types of polyphenols have been found to have significant antioxidant properties and may play a role in preventing age-related chronic diseases.
As aging progresses, the risk of various metabolic disorders increases. Dietary polyphenols could be a novel and potential health element for regulating glucose and lipid metabolism [30]. Studies have shown that an additional intake of 500 mg of flavonoids per day can reduce the risk of type 2 diabetes [30]. Metabolic-associated fatty liver disease (MAFLD), for instance, is the most common chronic liver disease globally. Studies have shown that certain polyphenols, such as curcumin, which belongs to the curcuminoids and is found in turmeric, may play a role in mitigating the effects of aging on metabolism. Jalali et al. [31] discovered through meta-analysis that curcumin supplements can reduce the activities of ALT and AST, as well as TC, LDL, FBS, HOMA-IR, and waist circumference. Furthermore, it has been experimentally proven that curcumin can lower the plasma lipid level and modify the lipid metabolism of C57BL/6 male mice with high-fat, high-fructose-induced NAFLD and alter the activity of cytochrome CYP3A and CYP7A both in vitro and in healthy rat models [32]. Experiments have proved that resveratrol, a stilbene abundantly present in grapes, can increase the number of mitochondria and citrate synthase activity [33]. In insulin-resistant rodents, resveratrol promotes intracellular glucose transport and enhances the ability of skeletal muscle to absorb insulin-stimulated glucose [34,35]. (-)-Epicatechin is a natural flavanol that can be used for preventing cardiovascular risk diseases. Studies have shown that (-)-epicatechin can increase the expression of apelin/APLNR and improve lipid abnormalities and lipid catabolism disorders in offspring caused by maternal obesity [36]. This suggests that dietary polyphenols may have the potential to modulate glucose and lipid metabolism, which is often disrupted during the aging process and contributes to the development of age-related metabolic disorders.
Polyphenols can also modulate immune system function by inhibiting NF-κB and MAPK/ERK pathways, inhibiting toll-like receptors (TLRs) and pro-inflammatory gene expression, suppressing the enzymes related to the production of ROS, and up-regulating other endogenous antioxidant enzymes [37]. As a kind of flavanol, epigallocatechin-3-gallate (EGCG) could affect the differentiation of immune cell CD4+ T-cell subsets and alleviate experimental autoimmune encephalomyelitis (EAE) [38]. Research has demonstrated that resveratrol can target sirtuin, adenosine monophosphate kinase, NF-κB, inflammatory cytokines, and antioxidant enzymes to inhibit the expression of TLRs and pro-inflammatory genes, thereby regulating the immunity of the organism [39]. Apigenin, a dietary flavonoid mainly derived from celery and chamomile, can suppress the autoantigen presentation and stimulation functions requisite for the activation and expansion of autoreactive Th1 and Th17 cells as well as B cells in systemic lupus erythematosus (SLE), an autoimmune disorder, by down-regulating the expression of COX-2 [40].
Oxidative damage is one of the important reasons for cellular aging and functional decline. Resveratrol, which has a significant connection with anti-aging, can remarkably extend the lifespan of several model organisms by regulating oxidative stress, energy metabolism, nutrient sensing, and epigenetics [41]. Resveratrol has been shown to lower anti-apoptotic and antioxidant capacity-related genes to delay ovarian aging in the oxidative stress model [42]. Studies have shown that EGCG can decrease the acetylation level of histones by reducing the activity of histone deacetylase (HDAC) and further regulate the expression of genes related to cell aging and anti-oxidative stress, thereby delaying aging [43]. Catechin is a kind of flavanol with a relatively high content in green tea, wine, and cocoa products. It can not only scavenge free radicals and metal ion chelators but also participate in various enzymatic reactions that detoxify some peroxides in cells, thus preventing diseases caused by stress [44]. Cocoa flavanols act as an activator of Nrf2 to increase the level of antioxidant proteins, protect against skeletal muscle damage, increase the abundance of mitochondrial proteins, and improve the walking ability of patients with peripheral artery disease [45]. Although the metabolism levels of polyphenols in the brain are low, flavonoids have been demonstrated to have neuroprotective and cognitively enhancing benefits by lowering oxidative stress and neuroinflammation. Flavonoids may potentially improve the cerebrovascular system, regulate adult neurogenesis, restore healthy brain function, and slow brain aging [46].
The bioavailability of polyphenols in the gastrointestinal tract is relatively low, mainly accumulating in the large intestine and being metabolized by the gut microbiota that transform intestinal polyphenols [47]. The interaction between polyphenols and gut microbiota is mutual. Taking the lipophilic polyphenol curcumin as an example, curcumin is mainly detected in the intestinal tract after oral administration. On the one hand, human gut microbiota such as Escherichia coli, Bifidobacterium longum, Bifidobacterium pseudocatenulaum, and Enterococcus faecalis can convert curcumin into other metabolites through acetylation, hydroxylation, reduction, and demethylation [48]. The metabolites of curcumin, such as demethylcurcumin and bisdemethoxycurcumin can increase the activity of Aβ degrading enzymes and reduce the accumulation of Aβ in the hippocampus and cortex of AD model mice. This neuroprotective effect is not characteristic of curcumin itself [49]. On the other hand, the antibacterial activity of polyphenols enables them to increase the proportion of beneficial bacteria such as Bifidobacteria, Lactobacilli, and butyrate-producing bacteria in the gut microbiota and reduce the number of pathogenic bacteria such as Prevotellaceae, Coriobacterales, Enterobacteria, and Rikenellaceae [48]. The amelioration of gut microbiota balance contributes to upholding the integrity of the intestinal barrier, curtailing the influx of harmful substances into the organism, and abating the occurrence frequency and intensity of inflammatory responses. In vitro studies have shown that in Caco-2 cells, curcumin pretreatment significantly attenuates the inflammatory factor IL-1β secreted by intestinal epithelial cells and macrophages induced by cyclic lipopolysaccharide, reduces intestinal barrier dysfunction, and regulates chronic inflammatory diseases [50]. Urolithin A (UA) is the gut microbiota metabolite of phenolic acids ellagic acid (EA). Studies have shown that UA can activate the Nrf2 pathway to enhance the gut barrier integrity [51]. Oral administration of EGCG can significantly enrich short-chain fatty acid-producing bacteria and enhance anti-inflammatory effects and gut barrier integrity [52]. Consuming 1391 mg/day of polyphenols for 8 weeks can decrease the serum connexin level and strengthen the intestinal barrier function in elders over 60 [53].
Taken together, polyphenol is an important category of plant-derived bioactive substances that positively impact human health in multiple ways, such as regulating the body’s metabolism, enhancing immune function, and delaying aging (Figure 2). Having a reasonable diet and consuming more fruits and vegetables rich in polyphenols can help improve health conditions and quality of life.

3. Natural Polyphenols for Anti-Aging Studies

Polyphenols are acknowledged as an essential part of the human diet, and epidemiological data indicate that consuming a diet high in antioxidant fruits and vegetables lowers the incidence of numerous oxidative stress-related disorders, including diabetes, cardiovascular disease, and cancer. Polyphenols show great antioxidant and anti-inflammatory properties, are also easily absorbed in the gut, and constitute a significant supply of antioxidants in the diet [54]. Variations in the antioxidant capacity of particular phenolic compounds are caused by the quantity and location of their hydroxyl groups. Dietary polyphenolic components can extend the lifespan of various model species by removing senescent cells, maintaining mitochondrial homeostasis, suppressing inflammatory response, restricting calories, increasing autophagy, and countering oxidative stress [12,55,56,57] (Figure 2). It may control energy metabolism, extending lifespan and good health while lowering the chance of age-related chronic diseases. Increasing evidence has demonstrated that dietary polyphenol intake may delay aging and treat age-related diseases (Table 1).

3.1. Ellagic Acid (EA)

EA is widely found in fruits and nuts, especially pomegranates, raspberries, and walnuts, and its content is considerable. There is also a general understanding that eating pomegranate can fight against aging. Several studies have demonstrated that EA has strong biochemical and biological activity, such as antioxidative, anti-inflammatory, and neuroprotective properties, and its metabolites also play a role in anti-aging [116]. EA can increase the longevity of Drosophila melanogaster, C. elegans, and mice by scavenging free radicals, activating antioxidant enzymes, and decreasing the production of ROS [116]. Studies have shown that EA increases resistance to UV radiation, oxidative stress, and Pseudomonas aeruginosa infection stress in C. elegans to extend lifespan. It also activates stress-related genes through the insulin-like growth factor-1 (IGF-1) signaling pathway to reduce DNA damage and enhance resistance to UV radiation [75].
EA can be converted to urolithin-A (UA) in the gut via the gut microbiota. UA is a novel natural chemical that has been proven to stimulate mitophagy both in vitro and in animals following administration and has a favorable safety profile. Despite a great deal of research on the benefits of EA in extending lifespan, it has been proposed that the effects of EA are mediated through its metabolite UA. With aging, UA promotes mitochondrial autophagy, maintains mitochondrial biogenesis and respiratory capacity in C. elegans, and extends lifespan [82]. Clinical research has demonstrated that after 28 days of oral treatment of 500 or 1000 mg of UA, mitochondrial activity of the elderly is significantly improved [79]. Additionally, UA stimulates mitochondrial autophagy and enhances muscular health. In conclusion, further research is still needed to determine whether EA or its metabolites contribute to extended lifespan.

3.2. Gallic Acid (GA)

GA is widely present in various plants, such as tea, pomegranate, grapes, and nuts. It possesses a broad spectrum of antioxidant, anti-inflammatory, antibacterial, antiviral, and antitumor properties. GA could protect against mitochondrial oxidative stress and inhibit DNA damage and apoptosis. Studies have shown that GA protects mitochondria against extreme oxidative stress, increasing the survival of neuronal cells in a mouse model of hypoxia/reperfusion brain injury [117]. As the most abundant and biologically active tea polyphenol, EGCG treatment attenuates neuronal apoptosis and neurodegeneration, ameliorates oxidative damage, and protects against neurodegeneration in rat brain [118]. Additionally, UV radiation is a key cause of photoaging in the skin, resulting in collagen loss and wrinkle formation. GA could stimulate collagen synthesis to enhance skin elasticity while reducing wrinkle formation [119].

3.3. Rutin

The natural flavonoid rutin, also known as quercetin-3-O-rutinoside and vitamin P, possesses relatively stable physicochemical properties and is widely distributed in citrus fruits and buckwheat seeds [120]. Rutin has been demonstrated to extend the lifespan and healthy lifespan of Drosophila melanogaster, C. elegans, and mice due to its antioxidant and anti-inflammatory effects. It exhibits a remarkable ability to selectively target senescent cells and efficiently suppress the production of CXCL8, which is a typical SASP effector, in senescent cells. Compared with the SASP-specific targeted medications rapamycin and metformin, rutin has a higher security profile as a natural product [121]. Furthermore, diabetes is a chronic disease associated with oxidative stress. Supplemented with rutin on a regular basis, it enhances the quality of life for those with type 2 diabetes mellitus by lowering blood pressure and elevating antioxidant enzyme levels [122]. Environmental pollutants phthalates and bisphenol A are detrimental to cardiovascular health, and rutin supplementation upregulates Nrf2 and inhibits the NF-κB signaling pathway to prevent toxic-induced oxidative stress and inflammation in the heart [123].

3.4. Quercetin

Quercetin is widely found in a variety of fruits and vegetables, such as onions, apples, berries, and broccoli. Quercetin is a potent antioxidant with anti-aging properties that scavenge free radicals and shield cells from oxidative stress-related cell damage. It also lessens the harm that inflammation causes to tissue and suppresses inflammatory reactions. Furthermore, quercetin postpones illnesses linked to aging and safeguards the neurological and cardiovascular systems.
Senolytics are a class of drugs that can slow down the physical dysfunction caused by senescent cells and selectively eliminate senescent cells [124]. Dasatinib, which removes senescent human adipocyte progenitors, and quercetin, which kills senescent human endothelial cells and mouse bone marrow stem cells, work together to provide a significant anti-aging effect [125]. As the first combination of drugs in the Senolytics regimen, they are able to specifically target and potently eliminate senescent cells [97]. Senolytic treatment with dasatinib and quercetin decreases intestinal cellular senescence and inflammatory burden while modulating gut microbiome in aged mice, alleviating intestinal senescence and inflammation [9]. Senolytics are employed not only to lessen the burden that senescent cells produce but also to prevent the physiological dysfunctions they can induce.
Frailty is a geriatric syndrome induced by multiple age-related physiological changes [126]. A lower chance of frailty is linked to a higher intake of dietary flavonols, particularly in quercetin. Research indicates that a daily increase of 10 mg in quercetin intake lowers the risk of frailty by 35% [127]. Additionally, flavonols can benefit skin health. Senescent fibroblast accumulation, chronic inflammation, and collagen remodeling in the skin lead to age-related skin aging, characterized by wrinkles and a loss in skin elasticity.

3.5. Fisetin

Fisetin is a unique antioxidant mostly present in strawberries and other fruits and vegetables. It is one of the rarer flavonoid components that may cross the blood–brain barrier [128]. Fisetin has a chemical structure similar to quercetin, except for a hydroxyl group in position 5. However, compared to quercetin, fisetin has greater anti-aging properties [129]. Fisetin not only has direct antioxidant activity, but it also increases glutathione levels, the primary antioxidant in cells. In oxidative stress, fisetin preserves mitochondrial function and protects neuronal cells from oxidative stress-induced death. Fisetin has been demonstrated to improve skin aging by selectively eliminating senescent dermal fibroblasts and blocking SASP release, making it a promising novel anti-aging medication [130]. Fisetin has also been proven to ameliorate cognitive impairment in rats and extend long-term memory [131,132]. Fisetin has the potential to slow down brain aging and skin aging and may lower the risk of age-related neurodegenerative illnesses.

3.6. Anthocyanins

Anthocyanins are a type of natural pigment in a wide range of foods, particularly berries such as black, blue, and raspberries, with powerful antioxidative effects that help enhance blood vessel health, prevent cancer, and maintain strong bones [133]. Despite comparatively poor bioavailability, anthocyanins are more readily accessible for disease prevention due to their fewer adverse effects and lower cost [134]. Oxidative stress is a significant factor in the aging process. As an intracellular lysosome-dependent metabolic process, autophagy removes damaged cells and proteins to prevent inflammatory responses and maintains physiological homeostasis. Bilberry anthocyanin has strong anti-inflammatory and antioxidant effects, which have been demonstrated to induce autophagy via the AMPK–mTOR signaling pathway, further enhancing resistance to oxidative stress and slowing down the aging process [135]. Oxidative stress also leads to reduced skin collagen synthesis and elevated levels of several pro-inflammatory cytokines, which can lead to wrinkles and plaques. The necessity of maintaining good skin health is becoming more widely recognized, and anthocyanins are one of the natural antioxidants that can be readily ingested from food. Carboxypyranocyanidin-3-O-glucoside has potent anti-aging properties for the skin because it not only scavenges ROS but also stimulates the activity of endogenous antioxidant enzymes such as glutathione peroxidase, catalase, and superoxide dismutase [136]. Additionally, its excellent structural stability is advantageous when it comes to cosmetic preparations for long-term storage.

4. Polyphenols and Hallmarks of Aging

In recent years, polyphenolic compounds have attracted much attention due to their potential anti-aging effects. Numerous studies have shown that polyphenols can significantly impact aging hallmarks by regulating various cellular pathways and physiological processes. This section will elaborate in detail on the close relationship between polyphenols and the 12 hallmarks of aging, aiming to provide a comprehensive and systematic perspective for an in-depth understanding of the mechanism of action of polyphenols in anti-aging (Figure 3). Based on these mechanisms, it is critical to develop more dietary polyphenols as daily supplements for the human body, as they are expected to delay the aging process and promote healthy aging.

4.1. Polyphenols and Mitochondrial Dysfunction

Some evidence suggests that oxidative stress is the cause or result of mitochondrial dysfunction, which leads to cellular aging and altered function. Mitochondria are the major site of aerobic respiration in cells [137]. With aging, mitochondrial DNA (mtDNA) lesions, ROS accumulation, mitochondrial biogenesis, mitochondrial fission and fusion, dysregulation of mitochondrial dynamics, and dysregulation of mitochondrial protein homeostasis contribute to mitochondrial impairment, resulting in a spectrum of age-related diseases, including NDs and cancer [138]. Therefore, repairing mitochondrial damage may provide the possibility of delaying aging as well as treating age-related diseases. Polyphenols are rich in phenolic hydroxyl groups and have a strong ability to capture ROS, which enables polyphenols to act as mitochondrial protectors and exert anti-aging effects through antioxidation, free radical scavenging, balancing mitochondrial fusion and fission, and maintaining mitochondrial morphology and distribution. As a premium antioxidant, polyphenols available from food can contribute to the prevention of aging.
The accumulation of lesions and replication errors can lead to mutations in mtDNA, which can induce mitochondrial diseases [139]. The mutations of mtDNA accumulate highly in the cells of aging individuals, which may lead to mitochondrial dysfunction and age-related diseases. Intervening in the generation and accumulation of mtDNA mutations will be a potential approach for the prevention and treatment of age-related diseases. Quercetin, as a nutritional supplement, can raise the amount of mtDNA and improve mitochondrial biogenesis, thus enhancing physical performance [140]. It has been established that quercetin can repair damaged mitochondrial membrane potential and mtDNA damage, together with improved mitochondrial dynamics [141]. A study has also demonstrated that low doses of resveratrol can improve mitochondrial respiratory dysfunction in mtDNA mutant cells [142].
In response to impaired mitochondrial function, cells initiate a stress response mechanism for repairing mitochondrial function and balancing intracellular homeostasis, known as mitochondrial unfolded protein response (UPRmt). The UPRmt is activated when mitochondria are slightly damaged, thus exerting a life-extending effect; when mitochondria are not damaged, the UPRmt can also be induced by a non-self-dwelling manner; when mitochondria are severely damaged beyond repair, they are degraded or cleared by autophagy [143]. Mitochondrial input is impaired when mitochondria are under stress, allowing activating transcription factor associated with stress (ATFS-1) to be transported into the nucleus and activate UPRmt, which regulates transcriptional processes to achieve the re-establishment of dynamic mitochondrial homeostasis [144]. Knockdown of the mitochondrial electron transport chain (ETC) subunit cytochrome c oxidase-1 (cco-1) in neurons has been shown to induce activation of UPRmt, which subsequently exerts beneficial effects on the entire organism, including lifespan extension, through mitochondrial responses located in the intestine [145]. Collectively, the activation of UPRmt is of critical importance for mitochondrial repair and even anti-aging research. As a dimethyl ether resveratrol analog, Pterostilbene is considered safe for human consumption. It was identified as a mitochondrial booster, which was found to be significantly enhanced in interaction with a mitochondrial cocktail (CoC3), which together increased the activity of sirtuins and activation of UPRmt, thus maintaining mitochondrial homeostasis and exerting neuroprotective, cardioprotective, and life-extending effects [146].
The fission and fusion of mitochondria are a dynamic process, regulated by multiple factors to adapt to the physiological needs of cells and environmental changes. When mitochondria suffer from DNA damage and protein aggregation, they may share healthy mitochondrial components through fusion. For example, resveratrol could improve cognitive impairment by increasing the size of hippocampal mitochondria through upregulating OPA1 and MFN2 proteins to promote mitochondrial fusion [147]. Furthermore, mitochondrial fusion can enhance mitochondrial function by diluting toxic superoxide, mutating mtDNA, and thus retarding the aging process of neuronal cells. Oxidative stress may lead to an increase in mitochondrial fission to remove the damaged mitochondrial parts. Mitochondrial fission is mainly regulated by dynamin-related protein 1 (DRP1), and rutin has been shown to repress mitochondrial fission. Cells treated with rutin after ethanol exposure showed reduced DRP1 expression, enhanced mitochondrial fusion, and an elongated morphology [148].

4.2. Polyphenols and Epigenetic Alterations

Epigenetics is a reversible genetic modification whose phenomena include DNA methylation, histone post-translational modification, and non-coding RNA [149,150]. Recent studies have reported that epigenetic changes are the main cause of aging in mammals, and that restoring epigenome integrity can reverse aging [151]. Dietary patterns, level of environmental pollution, lifestyle, and physical activity affect the molecular mechanisms of cells and the epigenome of cells and regulate gene expression, which in turn affects epigenetics and influences our life expectancy [149]. For the present, lifestyle changes and health service improvements are the main reasons for the increase in life expectancy in older adults.
DNA methylation elicits structural changes in chromatin and DNA, which is a relatively stable state of modification that can be hereditary to the next generation by the action of DNA methyltransferases. The alteration of DNA methylation is one of the major hallmarks of aging [152]. Reversing DNA methylation to slow overall aging may provide new insights into anti-aging research. Some studies have shown that GA has an inhibitory effect on DNA methylation and that GA has the ability to target aberrant epigenomes. DNMT1, a key enzyme involved in somatic cellular inheritance of DNA methylation, was significantly reduced in the nucleus or cytoplasm of GA-treated cells, and GA may be able to maintain the stability of the epigenome by inhibiting DNA methyltransferase (dnmt) [153]. GA-rich foods may exert anti-aging effects as an effective dietary intervention strategy.
Histones bind DNA into densely compressed chromatin and unbind parts of it if needed, and when they are unbundled, only then can they replicate, transcribe, and produce proteins. Accordingly, epigenetic factors can determine which genes are active or inactive in a given cell at a given time [151]. SIRT1 is an NAD+-dependent deacetylase. Resveratrol binds to SIRT1 at the amino-terminal site of the catalytic structural domain, increasing the affinity for acetylated substrates and constituting a metameric modification. Resveratrol has been proven to be an agonist of SIRT1. Resveratrol can increase AMPK activity, which in turn increases NAD+ concentration, leading to the activation of the SIRT1 pathway, thus exerting anti-aging effects [154].
Non-coding RNA includes snRNA, snoRNA, and microRNA (miRNA), of which miRNA is a type of evolutionarily conserved non-coding small-molecule RNA that regulates gene expression at the translational level. Quercetin has a wide range of biological activities and is also highly beneficial to human health from an epigenetic point of view. In different types of cancers, quercetin can regulate microRNAs. For example, it can increase the expression of miR-146a in breast cancer cells to inhibit tumor growth, and it can also regulate miR-146a in lung adenocarcinoma by affecting the K-Ras pathway [155]. Quercetin may also ameliorate cognitive dysfunction in AD animal models by reducing amyloid β-protein, tau phosphorylation, neuroinflammation, or modulating miRNAs such as miR-26a, miR-125b, and miR-132 [156]. After quercetin administration, liver-specific levels of miRNA miR-122, which is involved in lipid metabolism, promoting tumor cell apoptosis and inhibiting oncogene expression in the liver, were significantly elevated [157]. In addition, long-term quercetin supplementation increases miRNA expression in the hippocampus, ameliorates cognitive impairment, and slows the aging process [158].

4.3. Polyphenols and Disabled Macroautophagy

There are three main types of autophagy: macroautophagy, microautophagy, and molecular chaperone-mediated autophagy, where macroautophagy is the main form of autophagy. During autophagy, cytoplasmic material is segregated in double-membrane vesicles to form autophagosomes, fusing with lysosomes to digest luminal contents [159]. Autophagy plays an important role in intracellular homeostasis and is a self-regulatory process that arises in response to nutrient limitation, hypoxia, and endoplasmic reticulum stress [160]. Autophagy proactively degrades misfolded proteins or aggregates, removes superfluous, damaged, and harmful organelles, and maintains certain protein or lipid levels to safeguard normal cellular function [161]. Compromised autophagy is one of the newly added hallmarks of aging. Autophagy capacity decreases with aging, resulting in slower organelle renewal and metabolism and a decline in the body’s repair capacity, which predisposes the induction of various age-related diseases. Autophagy assumes a pivotal role in the therapy of NDs. Aberrant protein aggregation represents a prevalent pathological hallmark across various neurodegenerative disorders, and the pharmacological modulation of autophagy to enhance the elimination of misfolded proteins and other neurotoxic agents holds promising therapeutic implications for the management of NDs [162]. Polyphenols, as an accessible natural substance, can act as an autophagy inducer to promote the apoptosis of senescent cells, thereby exerting anti-aging effects.
α-Synuclein (α-Syn) is a soluble protein expressed presynaptically and perinuclear in the central nervous system, which is the main component of Lewy bodies. The aggregation of α-Syn and the formation of Lewy bodies are associated with neuronal death, both of which are pathologic hallmarks of PD [163]. Copper, as a trace metal, can promote the aggregation and misfolding of α-Syn protein, leading to the development of PD. Quercetin has been found to regulate the expression of endogenous α-Syn protein and enhance chaperone-mediated autophagy. Additionally, it can mitigate copper-induced apoptosis and endoplasmic reticulum stress in SH-SY5Y cells through autophagy [164]. These findings hold great promise for utilizing quercetin as a potential therapeutic agent for PD treatment.
Aβ is formed by the proteolytic cleavage of β-amyloid precursor protein by β and γ secretase, which is highly neurotoxic after precipitation and aggregation within the cell matrix. Aberrant accumulation of Aβ represents a prominent predisposing factor for AD [165]. Targeting the elimination of Aβ deposition can partially mitigate cognitive and functional decline, thereby delaying the onset of AD. Polyphenols in lychee seed exhibit inhibitory effects on Aβ (25–35)-induced NLRP3 inflammasome activation through the AMPK/mTOR/ULK1-mediated autophagy pathway, thereby safeguarding the integrity of the blood–brain barrier in AD [166].
Both AMPK and mTOR are classical inducers of autophagic responses during stress and exercise. EGCG is a polyphenol antioxidant found in a variety of teas with free radical scavenging properties, which can be replenished by simply drinking tea. By regulating the equilibrium of the mTOR–AMPK pathway upon endoplasmic reticulum stress, EGCG might encourage autophagy-dependent survival and boost cell viability [167]. As an autophagy inducer, resveratrol expands longevity. It mitigates aging symptoms through SIRT1-dependent induction of autophagic and non-autophagic pathways [34]. On the other hand, following resveratrol therapy, p38 was activated and enhanced autophagic flux in a dose-dependent manner, which could increase autophagy induced by the AMPK/p38MAPK pathway and exert a protective effect [168]. In conclusion, dietary polyphenol intake has some anti-aging effects and lowers the etiology of neuropathy and neurodegenerative disorders through autophagy.

4.4. Polyphenols and Deregulated Nutrient-Sensing

Nutrient sensing is the ability of a cell to perceive and react to energy substrates such as glucose, fatty acids, and ketones. Once these substrates are recognized, the cell affects gene expression and other signaling pathways for physiological processes. The insulin-like growth factor (IGF-1) signaling (IIS) pathway, the mTOR signaling pathway, and the AMPK pathway are the three pivotal pathways for nutrient sensing [5]. The dysregulation of nutrient sensing can lead to age-related and metabolic illnesses. Dietary restriction (DR) and calorie restriction (CR), which is the reduction in food intake without causing malnutrition, can mitigate many of the deleterious effects of aging and may be a promising way to improve health and longevity in humans [169,170]. A recent study utilizing the epigenomic DunedinPACE algorithm discovered that a 25% reduction in calorie intake slowed the rate of aging in healthy adults by 2% to 3%, which further supports the potential of CR in anti-aging [171]. Multiple genes in the cell that are sensitive to nutritional deficiency can be activated by CR, which causes the cell to stop growing and initiate the process of defending or repairing itself [172]. This causes the body’s antioxidant capacity to increase while the inflammatory response decreases. The production of the aging-associated protein Secreted Protein Acidic and Rich in Cysteine (SPARC), which prevents detrimental inflammation and enhances health in the elderly, is reduced by moderate CR [173]. Some polyphenols have the effect of calorie restriction mimics and can exert anti-aging effects by regulating nutrient sensing.
Resveratrol is a natural polyphenol that affects energy metabolism and mitochondrial function. Resveratrol was found to mimic CR in yeast as early as 20 years ago by increasing Sir2 expression, thereby enhancing DNA stability and extending lifespan by 70% [65]. It has been clinically proven that resveratrol supplementation can mimic the effects of CR by inducing metabolic changes in obese populations [174]. Researchers discovered that CR decreased the age-related SASP markers PAI-1 and MMP-9 and increased the anti-aging effects of dasatinib in combination with quercetin in middle-aged cynomolgus macaques [97].
In summary, polyphenols can exert the effects of DR by modulating metabolism, while moderate DR activates the AMPK pathway and increases inhibition of the rapamycin complex 1 (TORC1) pathway, increasing autophagy, degrading misfolded proteins and depleted organelles to maintain cellular homeostasis, and extending model organism lifespan. The AMPK pathway’s activation also encourages the action of the SIRT1 and FOXO factors, which help the cell withstand famine, nutritional shortages, and stress responses, thus expanding its lifespan.

4.5. Polyphenols and Chronic Inflammation

Age-related diseases such as osteoarthritis, atherosclerosis, and neuroinflammation are all accompanied by chronic inflammation, which indicates that chronic inflammation plays an important role in aging. Early studies showed that the cells of aged mice would exhibit a rejuvenated state when placed in the serum of young mice, while the cells of young mice would lose vitality in the serum of aged mice [175]. Further research demonstrated that the serum of young mice contained lower levels of inflammatory factors and presented a more favorable growth microenvironment. This phenomenon suggested that the key determinant of cell vitality was not the age of the cells but chronic inflammation. The factors secreted by senescent cells, including pro-inflammatory cytokines and chemokines, growth factors, angiogenic factors, and matrix metalloproteinases, are known as the SASP, which can promote chronic inflammation and induce senescence in normal cells. Failure to clear senescent cells and SASP will result in a vicious cycle of inflammation and aging [176].
The chronic inflammation resulting from the imbalance between the accumulation and clearance of ROS serves as a pathogenic factor for osteoarthritis (OA). Polyphenolic compounds exhibit anti-inflammatory and antioxidant activities and can suppress oxidative stress and inflammation in OA joints by suppressing the pro-inflammatory signaling pathways such as MAPK, AP1, and NF-κB [177]. Studies have shown that oral administration of quercetin may be able to inhibit the generation of ROS by activating the AMPK/SIRT signaling pathway to reduce inflammatory factors such as NO, MMP-3, and MMP-13, thereby improving the symptoms of OA rats [140]. Curcumin can effectively alleviate the pain caused by OA, protect against IL-1β-induced chondrocyte apoptosis, and inhibit the production of cPLA2, COX-2, and 5-LOX [178].
Neuroinflammation is the activation of glial cells caused by infections, NDs, or autoimmune diseases, which leads to the release of inflammatory mediators and causes damage to neurons. In the aging brain, the dysfunction of microglia and glial cells can lead to the persistence of chronic inflammation. Pomegranate (PU) has a strong antioxidant capacity and is widely found in pomegranates, raspberries, blueberries, and chestnuts. Studies have found that in accelerated aging and natural aging mouse models, PU not only reduces the activation of microglia and the proliferation of astrocytes, lowers the levels of MDA and ROS, but also inhibits the activation of NLRP3 inflammasomes, reduces oxidative stress responses, and related inflammatory cytokines such as IL-6, TNF-α, IL-18, and IL-1β [179]. Thus, PU could improve learning and memory deficits and prevent neuroinflammation.

4.6. Polyphenols and Genomic Instability

Genomic instability is driven by many endogenous and exogenous damages, resulting in increasing genomic alterations, involving damage to nuclear DNA (nDNA) and mtDNA, as well as changes in the structure and stability of chromosomes. Once DNA damage is not repaired in time, it will lead to incorrect genetic information transmission, interfere with the normal physiological functions of cells, and accelerate the aging process. Polyphenols primarily repair DNA damage through their antioxidant capacity, preserve genomic stability, and thus show anti-aging properties.
ROS has been demonstrated to be involved in regulating cell signal transduction and apoptosis and is one of the potential causes of DNA damage. EGCG could prevent CuO nanoparticle/H2O2-mediated DNA damage at very high concentrations due to its antioxidant behavior [180]. Radiation can also cause DNA damage. Studies have shown that pretreatment with 0.5 mM resveratrol before radiation can significantly reduce DNA damage, while the addition of 0.5 mM resveratrol during or after radiation is more effective in alleviating DNA damage caused by γ-rays [181].
ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3-related) kinases are crucial components of the intracellular DNA damage response mechanism. ATM responds to DNA double-strand breaks, while ATR responds to DNA single-strand damage and replication issues [182]. Once activated, they can suspend the cell cycle to gain time for repair and participate in the repair process. Research has indicated that the metabolites of procyanidins could alter the DNA damage response and promote the ATR–Chk1 and ATM–Chk2 pathways in vitro, reducing DNA damage in human lung epithelial cells and fetal hepatocytes induced by chemical carcinogens [183].

4.7. Polyphenols and Dysbiosis

The human gut is a highly diverse and dynamic micro-ecosystem with approximately 100 trillion microorganisms, and the species of which amount to several thousands. The aging process is typically accompanied by substantial alterations in the structure, abundance, and activity of the gut microbiota. Some animal studies have transferred the microbiota of feces from young animals to aged animals and found that the young microbiota reversed the manifestations related to aging [184,185,186]. Therefore, the gut microbiota is extensively involved in the processes of disease occurrence and development as well as aging by regulating the metabolic processes [187], inflammatory responses [188], and microbiota–gut–brain axis [189] of the organism.
Apart from directly consuming products containing probiotics, some specific foods have been scientifically proven to be capable of improving the gut microbiota. For instance, the Mediterranean diet, widely recognized as a healthy dietary pattern and is considered conducive to longevity, can significantly enhance the gut microbiota of the elderly and thereby improve their overall health status [190]. The Mediterranean diet provides a considerable amount of natural beneficial substances, among which dietary polyphenols constitute an important component. Oral administration of green tea polyphenol EGCG has been scientifically demonstrated to regulate the gut microbiota effectively, significantly inhibit the abundance of pathogenic bacteria, robustly enhance the integrity of the colonic barrier, and effectively alleviate colonic inflammation, which is highly beneficial to human health and simultaneously exhibits its considerable potential in anti-aging [52,191]. Furthermore, when chlorogenic acid and EGCG are used in combination, they can significantly enhance the anti-inflammatory and antioxidant effects, effectively inhibit the accumulation of ROS mediated by D-galactose, optimize the ratio of gut microbiota, maintain the diversity of microorganisms, and thereby alleviate intestinal aging [192]. The senolytic drug combination, Dasatinib plus Quercetin, can significantly reduce the contents of senescent cells and inflammatory factors in the small intestine and large intestine of mice and simultaneously regulate specific microbiota characteristics, thereby delaying intestinal inflammation and aging in mice [9]. Quercetin can also increase the abundance of beneficial microbiota in mice with pulmonary fibrosis, improve their intestinal flora imbalance, and delay the aging of alveolar epithelial cells [193].
Furthermore, certain dietary polyphenols mainly exert their anti-aging effects through their intestinal metabolites. UA is the metabolite of EA in the gut. Differences in individual ability to produce UA may cause significant individual variations in the health effects of EA. Studies have shown that in rat models with high UA production, administration of EA can improve memory and cognitive dysfunction while an increase in beneficial bacteria in the gut microbiota was observed [70]. Demethylcurcumin and bisdemethoxycurcumin are metabolites of curcumin in the gut, which have a neuroprotective effect on AD mice [48].

4.8. Polyphenols and Other Hallmarks of Aging

In addition to the above seven hallmarks of aging, polyphenols also play significant roles in altered cellular communication, stem cell exhaustion, cellular senescence, telomere attrition, and loss of proteostasis.
For instance, quercetin possesses remarkable antioxidant properties and can effectively reduce cellular oxidative stress damage, thereby maintaining normal physiological functions and communication capabilities of cells. Meanwhile, quercetin can also significantly decrease the release of SASPs, thereby regulating the communication between immune cells and maintaining the balance of the immune system [95]. EA could increase the proliferation of neural stem cells through the Wnt/β-catenin signaling pathway to assist in the treatment of nerve dysfunction and aging [72]. Rutin effectively delays aging by inhibiting the expression of the full-spectrum SASP and precisely targeting senescent cells [121]. Cy3G, as a natural inhibitor of CD38, can moderately increase the expression of telomerase reverse transcriptase, which is conducive to restoring the function and vitality of cells and extending the lifespan [109]. Impaired proteostasis is closely related to protein-conformational diseases like AD, PD, and prion diseases. Research indicates that EA can not only inhibit the formation but also disassemble the fibers of the prion protein, thus making it a promising candidate for the therapy of prion diseases [194].
In conclusion, numerous studies have shown that polyphenols have exerted significant benefits in every hallmark of aging. Whether it is the aging of cells, the deterioration of tissues, or the decline of the overall function of the organism, polyphenols have demonstrated positive and important roles.

5. Conclusions

With the hope that dietary polyphenols will eventually be utilized in place of pharmaceuticals to promote health, interest in polyphenol-rich natural products such as dietary supplements have increased significantly in recent years. Increasing evidence suggests that polyphenolic compounds such as EA, GA, rutin, quercetin, fisetin, and anthocyanins may promote health and extend lifespan in a variety of animal models through several mechanisms, genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. Aging and age-related diseases are intricate. This review synthesizes the 12 hallmarks of aging that have been newly put forward, highlighting the new evidence of anti-aging related to polyphenols. Aging is intrinsic and demands to be comprehended as a whole. Currently, studies typically commence from one or several hallmarks of aging. Regarding the anti-aging effect of polyphenols, each hallmark of aging should be regarded as a point of entry for future exploration of the aging process and the development of new anti-aging drugs. Furthermore, although various polyphenols have been proven to prevent or treat age-related diseases in various model organisms based on studies, there are still many vacancies in the aspect of clinical research.

6. Outstanding Questions

(1)
What factors cause individual differences in the metabolism and bioavailability of polyphenols in the body? How can the intake of polyphenols be optimized to achieve the best anti-aging effect?
(2)
What are the synergy mechanisms and dynamic regulation of the anti-aging effect of polyphenols?
(3)
Regarding the effects of polyphenols in the human body, what is their long-term efficacy like? And what conclusions have been drawn from the relevant safety clinical trials?
(4)
The aging process involves the interaction of multiple organs and systems, but existing studies mainly focus on individual hallmarks of aging. What is the comprehensive impact of polyphenols on the aging of multiple organ systems throughout the body?

Author Contributions

Y.L. wrote the manuscript and prepared the tables and figures. M.F. conceived of the topic and created the figures. X.T. and X.M. collected literature. L.Z., B.Y. and F.W. checked the tables and figures. S.F., L.C., C.H. and Y.-B.K. supervised the work and revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

No data availability.

Conflicts of Interest

Authors L.Z., B.Y., F.W. and L.C. were employed by the company Nutrilite Health Institute, Amway (Shanghai) Innovation and Science Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abbreviation

α-Syn, α-synuclein; Aβ, amyloid-β; ATFS-1, activating transcription factor associated with stress; ATR, ATM and Rad3-related; ATM, ataxia telangiectasia mutated; CR, calorie restriction; C. elegans, Caenorhabditis elegans; cco-1, cytochrome c oxidase-1; dnmt, DNA methyltransferase; DR, dietary restriction; DRP1, dynamin-related protein 1; EA, ellagic acid; EAE, experimental autoimmune encephalomyelitis; EGCG, epigallocatechin-3-gallate; ETC, electron transport chain; GA, gallic acid; HDAC, histone deacetylase; IGF-1, insulin-like growth factor-1; MAFLD, metabolic-associated fatty liver disease; miRNA, microRNA; NMN, nicotinamide mononucleotide; NDs, neurodegenerative diseases; nDNA, nuclear DNA; OA, osteoarthritis; PBMCs, human mononuclear cells; PPAR, peroxisome proliferator-activated receptor; PU, pomegranate; ROS, reactive oxygen species; SAMP8, senescence-accelerated mouse prone 8; SIRT1, silent information regulator 1; SLE, systemic lupus erythematosus; SPARC, secreted protein acidic and rich in cysteine; SD, Sprague-Dawley; TLRs, toll-like receptors.

References

  1. Tu, W.-J.; Zeng, X.; Liu, Q. Aging tsunami coming: The main finding from China’s seventh national population census. Aging Clin. Exp. Res. 2022, 34, 1159–1163. [Google Scholar] [CrossRef] [PubMed]
  2. Hou, Y.; Dan, X.; Babbar, M.; Wei, Y.; Hasselbalch, S.G.; Croteau, D.L.; Bohr, V.A. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 2019, 15, 565–581. [Google Scholar] [CrossRef] [PubMed]
  3. Schumacher, B.; Pothof, J.; Vijg, J.; Hoeijmakers, J.H.J. The central role of DNA damage in the ageing process. Nature 2021, 592, 695–703. [Google Scholar] [CrossRef]
  4. López-Otin, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. Hallmarks of aging: An expanding universe. Cell 2023, 186, 243–278. [Google Scholar] [CrossRef]
  5. López-Otín, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The Hallmarks of Aging. Cell 2013, 153, 1194–1217. [Google Scholar] [CrossRef]
  6. Moskalev, A.; Guvatova, Z.; Lopes, I.A.; Beckett, C.W.; Kennedy, B.K.; De Magalhaes, J.P.; Makarov, A.A. Targeting aging mechanisms: Pharmacological perspectives. Trends Endocrinol. Metab. 2022, 33, 266–280. [Google Scholar] [CrossRef]
  7. Ma, T.; Tian, X.; Zhang, B.D.; Li, M.Q.; Wang, Y.; Yang, C.Y.; Wu, J.F.; Wei, X.Y.; Qu, Q.; Yu, Y.X.; et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature 2022, 603, 159–165. [Google Scholar] [CrossRef] [PubMed]
  8. Nadeeshani, H.; Li, J.; Ying, T.; Zhang, B.; Lu, J. Nicotinamide mononucleotide (NMN) as an anti-aging health product—Promises and safety concerns. J. Adv. Res. 2022, 37, 267–278. [Google Scholar] [CrossRef]
  9. Saccon, T.D.; Nagpal, R.; Yadav, H.; Cavalcante, M.B.; Nunes, A.D.C.; Schneider, A.; Gesing, A.; Hughes, B.; Yousefzadeh, M.; Tchkonia, T.; et al. Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice. J. Gerontol. A Biol. Sci. Med. Sci. 2021, 76, 1895–1905. [Google Scholar] [CrossRef]
  10. Xu, T.T.; Li, H.; Dai, Z.; Lau, G.K.; Li, B.Y.; Zhu, W.L.; Liu, X.Q.; Liu, H.F.; Cai, W.W.; Huang, S.Q.; et al. Spermidine and spermine delay brain aging by inducing autophagy in SAMP8 mice. Aging 2020, 12, 6401–6414. [Google Scholar] [CrossRef]
  11. Luo, J.; Si, H.W.; Jia, Z.Q.; Liu, D.M. Dietary Anti-Aging Polyphenols and Potential Mechanisms. Antioxidants 2021, 10, 283. [Google Scholar] [CrossRef] [PubMed]
  12. Si, H.W.; Liu, D.M. Dietary antiaging phytochemicals and mechanisms associated with prolonged survival. J. Nutr. Biochem. 2014, 25, 581–591. [Google Scholar] [CrossRef]
  13. Li, J.; Liao, R.; Zhang, S.; Weng, H.; Liu, Y.; Tao, T.; Yu, F.; Li, G.; Wu, J. Promising remedies for cardiovascular disease: Natural polyphenol ellagic acid and its metabolite urolithins. Phytomedicine 2023, 116, 154867. [Google Scholar] [CrossRef]
  14. Benvenuto, M.; Albonici, L.; Focaccetti, C.; Ciuffa, S.; Fazi, S.; Cifaldi, L.; Miele, M.T.; De Maio, F.; Tresoldi, I.; Manzari, V.; et al. Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies. Int. J. Mol. Sci. 2020, 21, 6635. [Google Scholar] [CrossRef]
  15. Moradi, S.Z.; Jalili, F.; Farhadian, N.; Joshi, T.; Wang, M.; Zou, L.; Cao, H.; Farzaei, M.H.; Xiao, J. Polyphenols and neurodegenerative diseases: Focus on neuronal regeneration. Crit. Rev. Food Sci. Nutr. 2022, 62, 3421–3436. [Google Scholar] [CrossRef]
  16. Islam, M.A.; Khandker, S.S.; Kotyla, P.J.; Hassan, R. Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review. Front. Immunol. 2020, 11, 1477. [Google Scholar] [CrossRef]
  17. Long, Z.; Xiang, W.; He, Q.; Xiao, W.; Wei, H.; Li, H.; Guo, H.; Chen, Y.; Yuan, M.; Yuan, X.; et al. Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials. Front. Immunol. 2023, 14, 1024120. [Google Scholar] [CrossRef] [PubMed]
  18. La Rosa, G.; Lonardo, M.S.; Cacciapuoti, N.; Muscariello, E.; Guida, B.; Faraonio, R.; Santillo, M.; Damiano, S. Dietary Polyphenols, Microbiome, and Multiple Sclerosis: From Molecular Anti-Inflammatory and Neuroprotective Mechanisms to Clinical Evidence. Int. J. Mol. Sci. 2023, 24, 7247. [Google Scholar] [CrossRef]
  19. Grabska-Kobylecka, I.; Szpakowski, P.; Krol, A.; Ksiazek-Winiarek, D.; Kobylecki, A.; Glabinski, A.; Nowak, D. Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development. Nutrients 2023, 15, 3454. [Google Scholar] [CrossRef]
  20. Sandoval, V.; Sanz-Lamora, H.; Arias, G.; Marrero, P.F.; Haro, D.; Relat, J. Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral. Nutrients 2020, 12, 2393. [Google Scholar] [CrossRef]
  21. Gazwi, H.S.S.; Hassan, M.S.; Ismail, H.A.; El-Naem, G.F.A.; Tony, S.K. The Hypoglycemic and Hypolipidemic Effects of Polyphenol-Rich Strawberry Juice on Diabetic Rats. Plant Foods Hum. Nutr. 2023, 78, 512–519. [Google Scholar] [CrossRef] [PubMed]
  22. Wang, Y.; Liu, X.J.; Chen, J.B.; Cao, J.P.; Li, X.; Sun, C.D. Citrus flavonoids and their antioxidant evaluation. Crit. Rev. Food Sci. 2022, 62, 3833–3854. [Google Scholar] [CrossRef] [PubMed]
  23. Farzaei, M.H.; Singh, A.K.; Kumar, R.; Croley, C.R.; Pandey, A.K.; Coy-Barrera, E.; Kumar Patra, J.; Das, G.; Kerry, R.G.; Annunziata, G.; et al. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders. Int. J. Mol. Sci. 2019, 20, 4957. [Google Scholar] [CrossRef] [PubMed]
  24. Nomi, Y.; Iwasaki-Kurashige, K.; Matsumoto, H. Therapeutic Effects of Anthocyanins for Vision and Eye Health. Molecules 2019, 24, 3311. [Google Scholar] [CrossRef]
  25. Levenson, A.S. Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy. Semin. Cancer Biol. 2022, 80, 107–117. [Google Scholar] [CrossRef] [PubMed]
  26. Jang, W.Y.; Kim, M.Y.; Cho, J.Y. Antioxidant, Anti-Inflammatory, Anti-Menopausal, and Anti-Cancer Effects of Lignans and Their Metabolites. Int. J. Mol. Sci. 2022, 23, 15482. [Google Scholar] [CrossRef]
  27. Kozlowska, A.; Szostak-Wegierek, D. Flavonoids--food sources and health benefits. Rocz. Panstw. Zakl. Hig. 2014, 65, 79–85. [Google Scholar]
  28. Williamson, G.; Kay, C.D.; Crozier, A. The Bioavailability, Transport, and Bioactivity of Dietary Flavonoids: A Review from a Historical Perspective. Compr. Rev. Food Sci. F 2018, 17, 1054–1112. [Google Scholar] [CrossRef]
  29. Deng, Y.D.; Tu, Y.L.; Lao, S.H.; Wu, M.T.; Yin, H.T.; Wang, L.Q.; Liao, W.Z. The role and mechanism of citrus flavonoids in cardiovascular diseases prevention and treatment. Crit. Rev. Food Sci. 2022, 62, 7591–7614. [Google Scholar] [CrossRef]
  30. Xu, H.; Luo, J.; Huang, J.; Wen, Q. Flavonoids intake and risk of type 2 diabetes mellitus: A meta-analysis of prospective cohort studies. Medicine 2018, 97, e0686. [Google Scholar] [CrossRef] [PubMed]
  31. Jabczyk, M.; Nowak, J.; Hudzik, B.; Zubelewicz-Szkodzinska, B. Curcumin in Metabolic Health and Disease. Nutrients 2021, 13, 4440. [Google Scholar] [CrossRef]
  32. Yan, C.; Zhang, Y.; Zhang, X.; Aa, J.; Wang, G.; Xie, Y. Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice. Biomed. Pharmacother. 2018, 105, 274–281. [Google Scholar] [CrossRef] [PubMed]
  33. Nisoli, E.; Tonello, C.; Cardile, A.; Cozzi, V.; Bracale, R.; Tedesco, L.; Falcone, S.; Valerio, A.; Cantoni, O.; Clementi, E.; et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005, 310, 314–317. [Google Scholar] [CrossRef]
  34. Baur, J.A.; Pearson, K.J.; Price, N.L.; Jamieson, H.A.; Lerin, C.; Kalra, A.; Prabhu, V.V.; Allard, J.S.; Lopez-Lluch, G.; Lewis, K.; et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337–342. [Google Scholar] [CrossRef] [PubMed]
  35. Chen, L.L.; Zhang, H.H.; Zheng, J.; Hu, X.; Kong, W.; Hu, D.; Wang, S.X.; Zhang, P. Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial beta-oxidation. Metabolism 2011, 60, 1598–1609. [Google Scholar] [CrossRef] [PubMed]
  36. De los Santos, S.; Reyes-Castro, L.A.; Coral-Vázquez, R.M.; Mendez, J.P.; Zambrano, E.; Canto, P. (-)-Epicatechin increases apelin/APLNR expression and modifies proteins involved in lipid metabolism of offspring descendants of maternal obesity. J. Nutr. Biochem. 2023, 117, 109350. [Google Scholar] [CrossRef]
  37. Yahfoufi, N.; Alsadi, N.; Jambi, M.; Matar, C. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients 2018, 10, 1618. [Google Scholar] [CrossRef] [PubMed]
  38. Wang, J.; Pae, M.; Meydani, S.N.; Wu, D. Green tea epigallocatechin-3-gallate modulates differentiation of naïve CD4+ T cells into specific lineage effector cells. J. Mol. Med. 2013, 91, 485–495. [Google Scholar] [CrossRef]
  39. Malaguarnera, L. Influence of Resveratrol on the Immune Response. Nutrients 2019, 11, 946. [Google Scholar] [CrossRef]
  40. Kang, H.K.; Ecklund, D.; Liu, M.; Datta, S.K. Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res. Ther. 2009, 11, R59. [Google Scholar] [CrossRef]
  41. Pyo, I.S.; Yun, S.Y.; Yoon, Y.E.; Choi, J.W.; Lee, S.J. Mechanisms of Aging and the Preventive Effects of Resveratrol on Age-Related Diseases. Molecules 2020, 25, 4649. [Google Scholar] [CrossRef] [PubMed]
  42. Wang, J.; Jia, R.; Celi, P.; Zhuo, Y.; Ding, X.; Zeng, Q.; Bai, S.; Xu, S.; Yin, H.; Lv, L.; et al. Resveratrol Alleviating the Ovarian Function Under Oxidative Stress by Alternating Microbiota Related Tryptophan-Kynurenine Pathway. Front. Immunol. 2022, 13, 911381. [Google Scholar] [CrossRef]
  43. Han, D.W.; Lee, M.H.; Kim, H.H.; Hyon, S.H.; Park, J.C. Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts. Acta Pharmacol. Sin. 2011, 32, 637–646. [Google Scholar] [CrossRef]
  44. Bernatoniene, J.; Kopustinskiene, D.M. The Role of Catechins in Cellular Responses to Oxidative Stress. Molecules 2018, 23, 965. [Google Scholar] [CrossRef]
  45. Ismaeel, A.; McDermott, M.M.; Joshi, J.K.; Sturgis, J.C.; Zhang, D.X.; Ho, K.J.; Sufit, R.; Ferrucci, L.; Peterson, C.A.; Kosmac, K. Cocoa flavanols, Nrf2 activation, and oxidative stress in peripheral artery disease: Mechanistic findings in muscle based on outcomes from a randomized trial. Am. J. Physiol-Cell Ph 2024, 326, C589–C605. [Google Scholar] [CrossRef] [PubMed]
  46. Davinelli, S.; Medoro, A.; Ali, S.; Passarella, D.; Intrieri, M.; Scapagnini, G. Dietary Flavonoids and Adult Neurogenesis: Potential Implications for Brain Aging. Curr. Neuropharmacol. 2023, 21, 651–668. [Google Scholar] [CrossRef]
  47. Wan, M.L.Y.; Co, V.A.; El-Nezami, H. Dietary polyphenol impact on gut health and microbiota. Crit. Rev. Food Sci. 2021, 61, 690–711. [Google Scholar] [CrossRef]
  48. Scazzocchio, B.; Minghetti, L.; D’Archivio, M. Interaction between Gut Microbiota and Curcumin: A New Key of Understanding for the Health Effects of Curcumin. Nutrients 2020, 12, 2499. [Google Scholar] [CrossRef]
  49. Chen, P.T.; Chen, Z.T.; Hou, W.C.; Yu, L.C.; Chen, R.P. Polyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be applied to the prevention of Alzheimer’s disease. Sci. Rep. 2016, 6, 29760. [Google Scholar] [CrossRef] [PubMed]
  50. Wang, J.; Ghosh, S.S.; Ghosh, S. Curcumin improves intestinal barrier function: Modulation of intracellular signaling, and organization of tight junctions. Am. J. Physiol-Cell Ph 2017, 312, C438–C445. [Google Scholar] [CrossRef]
  51. Singh, R.; Chandrashekharappa, S.; Bodduluri, S.R.; Baby, B.V.; Hegde, B.; Kotla, N.G.; Hiwale, A.A.; Saiyed, T.; Patel, P.; Vijay-Kumar, M.; et al. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat. Commun. 2019, 10, 89. [Google Scholar] [CrossRef] [PubMed]
  52. Wu, Z.H.; Huang, S.M.; Li, T.T.; Li, N.; Han, D.D.; Zhang, B.; Xu, Z.J.Z.; Zhang, S.Y.; Pang, J.M.; Wang, S.L.; et al. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome 2021, 9, 184. [Google Scholar] [CrossRef]
  53. Del Bo, C.; Bernardi, S.; Cherubini, A.; Porrini, M.; Gargari, G.; Hidalgo-Liberona, N.; González-Domíniguez, R.; Zamora-Ros, R.; Peron, G.; Marino, M.; et al. A polyphenol-rich dietary pattern improves intestinal permeability, evaluated as serum zonulin levels, in older subjects: The MaPLE randomised controlled trial. Clin. Nutr. 2021, 40, 3006–3018. [Google Scholar] [CrossRef]
  54. Di Lorenzo, C.; Colombo, F.; Biella, S.; Stockley, C.; Restani, P. Polyphenols and Human Health: The Role of Bioavailability. Nutrients 2021, 13, 273. [Google Scholar] [CrossRef]
  55. Michalak, M. Plant-Derived Antioxidants: Significance in Skin Health and the Ageing Process. Int. J. Mol. Sci. 2022, 23, 585. [Google Scholar] [CrossRef]
  56. Joma, N.; Bielawski, P.B.; Saini, A.; Kakkar, A.; Maysinger, D. Nanocarriers for natural polyphenol senotherapeutics. Aging Cell 2024, 23, e14178. [Google Scholar] [CrossRef] [PubMed]
  57. Yessenkyzy, A.; Saliev, T.; Zhanaliyeva, M.; Masoud, A.R.; Umbayev, B.; Sergazy, S.; Krivykh, E.; Gulyayev, A.; Nurgozhin, T. Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research. Nutrients 2020, 12, 1344. [Google Scholar] [CrossRef] [PubMed]
  58. Harper, S.A.; Bassler, J.R.; Peramsetty, S.; Yang, Y.; Roberts, L.M.; Drummer, D.; Mankowski, R.T.; Leeuwenburgh, C.; Ricart, K.; Patel, R.P.; et al. Resveratrol and exercise combined to treat functional limitations in late life: A pilot randomized controlled trial. Exp. Gerontol. 2021, 143, 111111. [Google Scholar] [CrossRef] [PubMed]
  59. Huang, Y.; Zhu, X.; Chen, K.; Lang, H.; Zhang, Y.; Hou, P.; Ran, L.; Zhou, M.; Zheng, J.; Yi, L.; et al. Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway. Aging 2019, 11, 2217–2240. [Google Scholar] [CrossRef] [PubMed]
  60. Hosoda, R.; Nakashima, R.; Yano, M.; Iwahara, N.; Asakura, S.; Nojima, I.; Saga, Y.; Kunimoto, R.; Horio, Y.; Kuno, A. Resveratrol, a SIRT1 activator, attenuates aging-associated alterations in skeletal muscle and heart in mice. J. Pharmacol. Sci. 2023, 152, 112–122. [Google Scholar] [CrossRef]
  61. Gerhardt, E.; Graber, S.; Szego, E.M.; Moisoi, N.; Martins, L.M.; Outeiro, T.F.; Kermer, P. Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice. PLoS ONE 2011, 6, e28855. [Google Scholar] [CrossRef]
  62. Wood, J.G.; Rogina, B.; Lavu, S.; Howitz, K.; Helfand, S.L.; Tatar, M.; Sinclair, D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430, 686–689. [Google Scholar] [CrossRef] [PubMed]
  63. Chandrashekara, K.T.; Shakarad, M.N. Aloe vera or resveratrol supplementation in larval diet delays adult aging in the fruit fly, Drosophila melanogaster. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66, 965–971. [Google Scholar] [CrossRef]
  64. Zhu, H.; Li, X.; Qiao, M.; Sun, X.; Li, G. Resveratrol Alleviates Inflammation and ER Stress Through SIRT1/NRF2 to Delay Ovarian Aging in a Short-Lived Fish. J. Gerontol. A Biol. Sci. Med. Sci. 2023, 78, 596–602. [Google Scholar] [CrossRef] [PubMed]
  65. Howitz, K.T.; Bitterman, K.J.; Cohen, H.Y.; Lamming, D.W.; Lavu, S.; Wood, J.G.; Zipkin, R.E.; Chung, P.; Kisielewski, A.; Zhang, L.L.; et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425, 191–196. [Google Scholar] [CrossRef] [PubMed]
  66. Santos, M.A.; Franco, F.N.; Caldeira, C.A.; de Araujo, G.R.; Vieira, A.; Chaves, M.M. Resveratrol has its antioxidant and anti-inflammatory protective mechanisms decreased in aging. Arch. Gerontol. Geriatr. 2023, 107, 104895. [Google Scholar] [CrossRef]
  67. Bellaver, B.; Souza, D.G.; Souza, D.O.; Quincozes-Santos, A. Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats. Toxicol. In Vitro 2014, 28, 479–484. [Google Scholar] [CrossRef]
  68. Allen, E.N.; Potdar, S.; Tapias, V.; Parmar, M.; Mizuno, C.S.; Rimando, A.; Cavanaugh, J.E. Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism. J. Nutr. Biochem. 2018, 54, 77–86. [Google Scholar] [CrossRef]
  69. Amakura, Y.; Okada, M.; Tsuji, S.; Tonogai, Y. High-performance liquid chromatographic determination with photodiode array detection of ellagic acid in fresh and processed fruits. J. Chromatogr. A 2000, 896, 87–93. [Google Scholar] [CrossRef]
  70. Xian, W.Y.; Deng, Y.; Yang, Y.Z.; Tan, Z.L.; Chen, C.L.; Li, W.; Yang, R.L. Ameliorative Effect of Ellagic Acid on Aging in Rats with the Potential Mechanism Relying on the Gut Microbiota and Urolithin A-Producing Ability. J. Agric. Food Chem. 2023, 71, 7396–7407. [Google Scholar] [CrossRef]
  71. Naiini, M.R.; Shahouzehi, B.; Khaksari, M.; Azizi, S.; Naghibi, N.; Nazari-Robati, M. Ellagic acid reduces hepatic lipid contents through regulation of SIRT1 and AMPK in old rats. Arch. Physiol. Biochem. 2023, 10, 1–8. [Google Scholar] [CrossRef]
  72. Liu, Q.S.; Li, S.R.; Li, K.Q.; Li, X.; Yin, X.Y.; Pang, Z.R. Ellagic acid improves endogenous neural stem cells proliferation and neurorestoration through Wnt/β-catenin signaling in vivo and in vitro. Mol. Nutr. Food Res. 2017, 61, 1600587. [Google Scholar] [CrossRef]
  73. Dong, H.; Cao, Y.X.; Zou, K.; Shao, Q.; Liu, R.H.; Zhang, Y.; Pan, L.Z.; Ning, B. Ellagic acid promotes osteoblasts differentiation via activating SMAD2/3 pathway and alleviates bone mass loss in OVX mice. Chem-Biol. Interact. 2024, 388, 110852. [Google Scholar] [CrossRef] [PubMed]
  74. Bae, J.Y.; Choi, J.S.; Kang, S.W.; Lee, Y.J.; Park, J.; Kang, Y.H. Dietary compound ellagic acid alleviates skin wrinkle and inflammation induced by UV-B irradiation. Exp. Dermatol. 2010, 19, E182–E190. [Google Scholar] [CrossRef]
  75. Bai, S.J.; Yu, Y.R.; An, L.; Wang, W.B.; Fu, X.Q.; Chen, J.; Ma, J.F. Ellagic Acid Increases Stress Resistance via Insulin/IGF-1 Signaling Pathway in Caenorhabditis elegans. Molecules 2022, 27, 6168. [Google Scholar] [CrossRef]
  76. Kharat, P.; Sarkar, P.; Mouliganesh, S.; Tiwary, V.; Priya, V.B.R.; Sree, N.Y.; Annapoorna, H.V.; Saikia, D.K.; Mahanta, K.; Thirumurugan, K. Ellagic acid prolongs the lifespan of Drosophila melanogaster. Geroscience 2020, 42, 271–285. [Google Scholar] [CrossRef]
  77. Rahimi, V.B.; Askari, V.R.; Mousavi, S.H. Ellagic acid reveals promising anti-aging effects against D-galactose-induced aging on human neuroblastoma cell line, SH-SY5Y: A mechanistic study. Biomed. Pharmacother. 2018, 108, 1712–1724. [Google Scholar] [CrossRef] [PubMed]
  78. Duckworth, C.; Stutts, J.; Clatterbuck, K.; Nosoudi, N. Effect of ellagic acid and retinoic acid on collagen and elastin production by human dermal fibroblasts. Bio-Med. Mater. Eng. 2023, 34, 473–480. [Google Scholar] [CrossRef]
  79. Andreux, P.A.; Blanco-Bose, W.; Ryu, D.; Burdet, F.; Ibberson, M.; Aebischer, P.; Auwerx, J.; Singh, A.; Rinsch, C. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat. Metab. 2019, 1, 595–603. [Google Scholar] [CrossRef]
  80. Zhang, M.W.; Tang, X.; Mao, B.Y.; Zhang, Q.X.; Zhao, J.X.; Chen, W.; Cui, S.M. Inhibition of the NF-κB and mTOR targets by urolithin A attenuates d-galactose-induced aging in mice. Food Funct. 2023, 14, 10375–10386. [Google Scholar] [CrossRef]
  81. Ballesteros-Alvarez, J.; Nguyen, W.; Sivapatham, R.; Rane, A.; Andersen, J.K. Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease. Geroscience 2023, 45, 1095–1113. [Google Scholar] [CrossRef] [PubMed]
  82. Ryu, D.; Mouchiroud, L.; Andreux, P.A.; Katsyuba, E.; Moullan, N.; Nicolet-dit-Félix, A.A.; Williams, E.G.; Jha, P.; Lo Sasso, G.; Huzard, D.; et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 2016, 22, 879–888. [Google Scholar] [CrossRef] [PubMed]
  83. Chen, P.; Chen, F.C.; Lei, J.X.; Li, Q.L.; Zhou, B.H. Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates d-Galactose-Induced Brain Aging in Mice. Neurotherapeutics 2019, 16, 1269–1282. [Google Scholar] [CrossRef] [PubMed]
  84. Chen, P.; Lei, J.X.; Chen, F.C.; Zhou, B.H. Ameliorative effect of urolithin A on d-gal-induced liver and kidney damage in aging mice: Its antioxidative, anti-inflammatory and antiapoptotic properties. RSC Adv. 2020, 10, 8027–8038. [Google Scholar] [CrossRef]
  85. Guo, L.; Cao, J.H.; Wei, T.T.; Li, J.H.; Feng, Y.K.; Wang, L.P.; Sun, Y.; Chai, Y.R. Gallic acid attenuates thymic involution in the D-galactose induced accelerated aging mice. Immunobiology 2020, 225, 151870. [Google Scholar] [CrossRef]
  86. Rahimifard, M.; Baeeri, M.; Bahadar, H.; Moini-Nodeh, S.; Khalid, M.; Haghi-Aminjan, H.; Mohammadian, H.; Abdollahi, M. Therapeutic Effects of Gallic Acid in Regulating Senescence and Diabetes; an In Vitro Study. Molecules 2020, 25, 5875. [Google Scholar] [CrossRef]
  87. Mori, T.; Koyama, N.; Yokoo, T.; Segawa, T.; Maeda, M.; Sawmiller, D.; Tan, J.; Town, T. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice. J. Biol. Chem. 2020, 295, 16251–16266. [Google Scholar] [CrossRef]
  88. Ghorbani, A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomed. Pharmacother. 2017, 96, 305–312. [Google Scholar] [CrossRef]
  89. Chattopadhyay, D.; Thirumurugan, K. Longevity-promoting efficacies of rutin in high fat diet fed. Biogerontology 2020, 21, 653–668. [Google Scholar] [CrossRef] [PubMed]
  90. Cordeiro, L.M.; Machado, M.L.; da Silva, A.F.; Baptista, F.B.O.; da Silveira, T.L.; Soares, F.A.A.; Arantes, L.P. Rutin protects Huntington’s disease through the insulin/IGF1 (IIS) signaling pathway and autophagy activity: Study in model. Food Chem. Toxicol. 2020, 141, 111323. [Google Scholar] [CrossRef] [PubMed]
  91. Saafan, S.M.; Mohamed, S.A.; Noreldin, A.E.; El Tedawy, F.A.; Elewa, Y.H.A.; Fadly, R.S.; Al Jaouni, S.K.; El-Far, A.H.; Alsenosy, A.A. Rutin attenuates d-galactose-induced oxidative stress in rats’ brain and liver: Molecular docking and experimental approaches. Food Funct. 2023, 14, 5728–5751. [Google Scholar] [CrossRef]
  92. Li, T.Y.; Chen, S.F.; Feng, T.; Dong, J.; Li, Y.Y.; Li, H. Rutin protects against aging-related metabolic dysfunction. Food Funct. 2016, 7, 1147–1154. [Google Scholar] [CrossRef] [PubMed]
  93. Bermejo-Bescós, P.; Jiménez-Aliaga, K.L.; Benedí, J.; Martín-Aragón, S. A Diet Containing Rutin Ameliorates Brain Intracellular Redox Homeostasis in a Mouse Model of Alzheimer’s Disease. Int. J. Mol. Sci. 2023, 24, 4863. [Google Scholar] [CrossRef]
  94. Cui, Z.F.; Zhao, X.T.; Amevor, F.K.; Du, X.X.; Wang, Y.; Li, D.Y.; Shu, G.; Tian, Y.F.; Zhao, X.L. Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism. Front. Immunol. 2022, 13, 943321. [Google Scholar] [CrossRef] [PubMed]
  95. Islam, M.T.; Tuday, E.; Allen, S.; Kim, J.; Trott, D.W.; Holland, W.L.; Donato, A.J.; Lesniewski, L.A. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age. Aging Cell 2023, 22, e13767. [Google Scholar] [CrossRef] [PubMed]
  96. Novais, E.J.; Tran, V.A.; Johnston, S.N.; Darris, K.R.; Roupas, A.J.; Sessions, G.A.; Shapiro, I.M.; Diekman, B.O.; Risbud, M.V. Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat. Commun. 2021, 12, 5213. [Google Scholar] [CrossRef]
  97. Ruggiero, A.D.; Vemuri, R.; Blawas, M.; Long, M.S.; DeStephanis, D.; Williams, A.G.; Chen, H.Y.; Justice, J.N.; Macauley, S.I.; Day, S.M.; et al. Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: Implications for senolytic clinical trial design. Geroscience 2023, 45, 2785–2803. [Google Scholar] [CrossRef] [PubMed]
  98. Xu, M.; Pirtskhalava, T.; Farr, J.N.; Weigand, B.M.; Palmer, A.K.; Weivoda, M.M.; Inman, C.L.; Ogrodnik, M.B.; Hachfeld, C.M.; Fraser, D.G.; et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 2018, 24, 1246–1256. [Google Scholar] [CrossRef] [PubMed]
  99. Khajevand-Khazaei, M.R.; Ziaee, P.; Motevalizadeh, S.A.; Rohani, M.; Afshin-Majd, S.; Baluchnejadmojarad, T.; Roghani, M. Naringenin ameliorates learning and memory impairment following systemic lipopolysaccharide challenge in the rat. Eur. J. Pharmacol. 2018, 826, 114–122. [Google Scholar] [CrossRef]
  100. Chen, G.P.; Zeng, L.; Yan, F.; Liu, J.L.; Qin, M.Q.; Wang, F.F.; Zhang, X. Long-term oral administration of naringenin counteracts aging-related retinal degeneration regulation of mitochondrial dynamics and autophagy. Front. Pharmacol. 2022, 13, 919905. [Google Scholar] [CrossRef]
  101. Piragine, E.; De Felice, M.; Germelli, L.; Brinkmann, V.; Flori, L.; Martini, C.; Calderone, V.; Ventura, N.; Da Pozzo, E.; Testai, L. The Citrus flavanone naringenin prolongs the lifespan in C. elegans and slows signs of brain aging in mice. Exp. Gerontol. 2024, 194, 112495. [Google Scholar] [CrossRef]
  102. Chen, W.; Chu, Q.; Ye, X.; Sun, Y.H.; Liu, Y.Y.; Jia, R.Y.; Li, Y.L.; Tu, P.C.; Tang, Q.; Yu, T.; et al. Canidin-3-glucoside prevents nano-plastics induced toxicity activating autophagy and promoting discharge. Environ. Pollut. 2021, 274, 116524. [Google Scholar] [CrossRef]
  103. Sanjay; Shin, J.H.; Park, M.; Lee, H.J. Cyanidin-3-Glucoside Regulates the M1/M2 Polarization of Microglia via PPARγ and Aβ42 Phagocytosis Through TREM2 in an Alzheimer’s Disease Model. Mol. Neurobiol. 2022, 59, 5135–5148. [Google Scholar] [CrossRef]
  104. Baek, H.; Sanjay; Park, M.; Lee, H.J. Cyanidin-3-O-glucoside protects the brain and improves cognitive function in APPswe/PS1ΔE9 transgenic mice model. J. Neuroinflamm. 2023, 20, 268. [Google Scholar] [CrossRef] [PubMed]
  105. Qin, L.N.; Zhang, J.L.; Qin, M.L. Protective effect of cyanidin 3-O-glucoside on beta-amyloid peptide-induced cognitive impairment in rats. Neurosci. Lett. 2013, 534, 285–288. [Google Scholar] [CrossRef]
  106. Jaiswal, V.; Park, M.; Lee, H.J. Comparative Transcriptome Analysis of the Expression of Antioxidant and Immunity Genes in the Spleen of a Cyanidin 3-O-Glucoside-Treated Alzheimer’s Mouse Model. Antioxidants 2021, 10, 1435. [Google Scholar] [CrossRef]
  107. Wang, W.; Zhu, G.X.; Wang, Y.W.; Li, W.; Yi, S.L.; Wang, K.; Fan, L.; Tang, J.J.; Chen, R.N. Multi-Omics Integration in Mice with Parkinson’s Disease and the Intervention Effect of Cyanidin-3-Glucoside. Front. Aging Neurosci. 2022, 14, 877078. [Google Scholar] [CrossRef]
  108. Chen, W.; Chen, Z.; Shan, S.; Wu, A.B.; Zhao, C.; Ye, X.; Zheng, X.D.; Zhu, R.Y. Cyanidin-3-O-glucoside promotes stress tolerance and lifespan extension of exposed to polystyrene via DAF-16 pathway. Mech. Ageing Dev. 2022, 207, 111723. [Google Scholar] [CrossRef]
  109. Zhou, H.J.; Liu, S.A.; Zhang, N.Y.; Fang, K.H.; Zong, J.B.; An, Y.; Chang, X.T. Downregulation of Sirt6 by CD38 promotes cell senescence and aging. Aging 2022, 14, 9730–9757. [Google Scholar] [CrossRef] [PubMed]
  110. Xu, Q.; Fu, Q.; Li, Z.; Liu, H.; Wang, Y.; Lin, X.; He, R.; Zhang, X.; Ju, Z.; Campisi, J.; et al. The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice. Nat. Metab. 2021, 3, 1706–1726. [Google Scholar] [CrossRef]
  111. Liu, Y.; Liu, X.; Chen, X.; Yang, Z.; Chen, J.; Zhu, W.; Li, Y.; Wen, Y.; Deng, C.; Gu, C.; et al. Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retina. Proc. Natl. Acad. Sci. USA 2024, 121, e2311028121. [Google Scholar] [CrossRef] [PubMed]
  112. Strong, R.; Miller, R.A.; Astle, C.M.; Floyd, R.A.; Flurkey, K.; Hensley, K.L.; Javors, M.A.; Leeuwenburgh, C.; Nelson, J.F.; Ongini, E.; et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 2008, 7, 641–650. [Google Scholar] [CrossRef] [PubMed]
  113. Chang, J.; Rimando, A.; Pallas, M.; Camins, A.; Porquet, D.; Reeves, J.; Shukitt-Hale, B.; Smith, M.A.; Joseph, J.A.; Casadesus, G. Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer’s disease. Neurobiol. Aging 2012, 33, 2062–2071. [Google Scholar] [CrossRef] [PubMed]
  114. La Spina, M.; Sansevero, G.; Biasutto, L.; Zoratti, M.; Peruzzo, R.; Berardi, N.; Sale, A.; Azzolini, M. Pterostilbene Improves Cognitive Performance in Aged Rats: An in Vivo Study. Cell Physiol. Biochem. 2019, 52, 232–239. [Google Scholar] [CrossRef] [PubMed]
  115. Joseph, J.A.; Fisher, D.R.; Cheng, V.; Rimando, A.M.; Shukitt-Hale, B. Cellular and behavioral effects of stilbene resveratrol analogues: Implications for reducing the deleterious effects of aging. J. Agric. Food Chem. 2008, 56, 10544–10551. [Google Scholar] [CrossRef] [PubMed]
  116. Zhu, H.Y.; Yan, Y.M.; Jiang, Y.; Meng, X.F. Ellagic Acid and Its Anti-Aging Effects on Central Nervous System. Int. J. Mol. Sci. 2022, 23, 10937. [Google Scholar] [CrossRef] [PubMed]
  117. Sun, J.; Li, Y.Z.; Ding, Y.H.; Wang, J.; Geng, J.; Yang, H.; Ren, J.; Tang, J.Y.; Gao, J. Neuroprotective effects of gallic acid against hypoxia/reoxygenation-induced mitochondrial dysfunctions in vitro and cerebral ischemia/reperfusion injury in vivo. Brain Res. 2014, 1589, 126–139. [Google Scholar] [CrossRef]
  118. Wang, L.L.; Tian, X. Epigallocatechin-3-Gallate Protects against Homocysteine-Induced Brain Damage in Rats. Planta Med. 2018, 84, 34–41. [Google Scholar] [CrossRef]
  119. Hwang, E.; Park, S.Y.; Lee, H.J.; Lee, T.Y.; Sun, Z.W.; Yi, T.H. Gallic Acid Regulates Skin Photoaging in UVB-exposed Fibroblast and Hairless Mice. Phytother. Res. 2014, 28, 1778–1788. [Google Scholar] [CrossRef] [PubMed]
  120. Chattopadhyay, D.; Chitnis, A.; Talekar, A.; Mulay, P.; Makkar, M.; James, J.; Thirumurugan, K. Hormetic efficacy of rutin to promote longevity in. Biogerontology 2017, 18, 397–411. [Google Scholar] [CrossRef]
  121. Liu, H.X.; Xu, Q.X.; Wufuer, H.; Li, Z.; Sun, R.; Jiang, Z.R.; Dou, X.F.; Fu, Q.; Campisi, J.; Sun, Y. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy. Aging Cell 2024, 23, e13921. [Google Scholar] [CrossRef] [PubMed]
  122. Bazyar, H.; Javid, A.Z.; Ahangarpour, A.; Zaman, F.; Hosseini, S.A.; Zohoori, V.; Aghamohammadi, V.; Yazdanfar, S.; Cheshmeh, M.G.D. The effects of rutin supplement on blood pressure markers, some serum antioxidant enzymes, and quality of life in patients with type 2 diabetes mellitus compared with placebo. Front. Nutr. 2023, 10, 1214420. [Google Scholar] [CrossRef] [PubMed]
  123. Oluranti, O.I.; Alabi, B.A.; Michael, O.S.; Ojo, A.O.; Fatokun, B.P. Rutin prevents cardiac oxidative stress and inflammation induced by bisphenol A and dibutyl phthalate exposure via NRF-2/NF-κB pathway. Life Sci. 2021, 284, 119878. [Google Scholar] [CrossRef] [PubMed]
  124. Kirkland, J.L.; Tchkonia, T. Senolytic drugs: From discovery to translation. J. Intern. Med. 2020, 288, 518–536. [Google Scholar] [CrossRef]
  125. Zhu, Y.; Tchkonia, T.; Pirtskhalava, T.; Gower, A.C.; Ding, H.S.; Giorgadze, N.; Palmer, A.K.; Ikeno, Y.; Hubbard, G.B.; Lenburg, M.; et al. The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell 2015, 14, 644–658. [Google Scholar] [CrossRef] [PubMed]
  126. Yannakoulia, M.; Ntanasi, E.; Anastasiou, C.A.; Scarmeas, N. Frailty and nutrition: From epidemiological and clinical evidence to potential mechanisms. Metabolism 2017, 68, 64–76. [Google Scholar] [CrossRef]
  127. Oei, S.; Millar, C.L.; Lily, T.N.N.; Mukamal, K.J.; Kiel, D.P.; Lipsitz, L.A.; Hannan, M.T.; Sahni, S. Higher intake of dietary flavonols, specifically dietary quercetin, is associated with lower odds of frailty onset over 12 years of follow-up among adults in the Framingham Heart Study. Am. J. Clin. Nutr. 2023, 118, 27–33. [Google Scholar] [CrossRef]
  128. Maher, P. Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin. Genes. Nutr. 2009, 4, 297–307. [Google Scholar] [CrossRef]
  129. Yousefzadeh, M.J.; Zhu, Y.; McGowan, S.J.; Angelini, L.; Fuhrmann-Stroissnigg, H.; Xu, M.; Ling, Y.Y.; Melos, K.I.; Pirtskhalava, T.; Inman, C.L.; et al. Fisetin is a senotherapeutic that extends health and lifespan. Ebiomedicine 2018, 36, 18–28. [Google Scholar] [CrossRef]
  130. Takaya, K.; Asou, T.; Kishi, K. Fisetin, a potential skin rejuvenation drug that eliminates senescent cells in the dermis. Biogerontology 2024, 25, 161–175. [Google Scholar] [CrossRef]
  131. Ding, H.G.; Li, Y.; Chen, S.L.; Wen, Y.; Zhang, S.Y.; Luo, E.S.; Li, X.S.; Zhong, W.H.; Zeng, H.K. Fisetin ameliorates cognitive impairment by activating mitophagy and suppressing neuroinflammation in rats with sepsis-associated encephalopathy. Cns Neurosci. Ther. 2022, 28, 247–258. [Google Scholar] [CrossRef]
  132. Maher, P.; Akaishi, T.; Abe, K. Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc. Natl. Acad. Sci. USA 2006, 103, 16568–16573. [Google Scholar] [CrossRef]
  133. Hair, R.; Sakaki, J.R.; Chun, O.K. Anthocyanins, Microbiome and Health Benefits in Aging. Molecules 2021, 26, 537. [Google Scholar] [CrossRef]
  134. Sharma, P.; McClees, S.F.; Afaq, F. Pomegranate for Prevention and Treatment of Cancer: An Update. Molecules 2017, 22, 177. [Google Scholar] [CrossRef]
  135. Li, J.; Zhao, R.T.; Zhao, H.; Chen, G.Y.; Jiang, Y.H.; Lyu, X.L.; Wu, T. Reduction of Aging-Induced Oxidative Stress and Activation of Autophagy by Bilberry Anthocyanin Supplementation via the AMPK-mTOR Signaling Pathway in Aged Female Rats. J. Agric. Food Chem. 2019, 67, 7832–7843. [Google Scholar] [CrossRef]
  136. Correia, P.; Araújo, P.; Ribeiro, C.; Oliveira, H.; Pereira, A.R.; Mateus, N.; de Freitas, V.; Bras, N.F.; Gameiro, P.; Coelho, P.; et al. Anthocyanin-Related Pigments: Natural Allies for Skin Health Maintenance and Protection. Antioxidants 2021, 10, 1038. [Google Scholar] [CrossRef]
  137. Kudryavtseva, A.V.; Krasnov, G.S.; Dmitriev, A.A.; Alekseev, B.Y.; Kardymon, O.L.; Sadritdinova, A.F.; Fedorova, M.S.; Pokrovsky, A.V.; Melnikova, N.V.; Kaprin, A.D.; et al. Mitochondrial dysfunction and oxidative stress in aging and cancer. Oncotarget 2016, 7, 44879–44905. [Google Scholar] [CrossRef]
  138. Annesley, S.J.; Fisher, P.R. Mitochondria in Health and Disease. Cells 2019, 8, 680. [Google Scholar] [CrossRef]
  139. Park, C.B.; Larsson, N.G. Mitochondrial DNA mutations in disease and aging. J. Cell Biol. 2011, 193, 809–818. [Google Scholar] [CrossRef] [PubMed]
  140. Qiu, L.; Luo, Y.J.; Chen, X.J. Quercetin attenuates mitochondrial dysfunction and biogenesis via upregulated AMPK/SIRT1 signaling pathway in OA rats. Biomed. Pharmacother. 2018, 103, 1585–1591. [Google Scholar] [CrossRef]
  141. Zhao, X.; Wang, C.; Dai, S.; Liu, Y.; Zhang, F.; Peng, C.; Li, Y. Quercetin Protects Ethanol-Induced Hepatocyte Pyroptosis via Scavenging Mitochondrial ROS and Promoting PGC-1alpha-Regulated Mitochondrial Homeostasis in L02 Cells. Oxid. Med. Cell Longev. 2022, 2022, 4591134. [Google Scholar] [CrossRef] [PubMed]
  142. Mizuguchi, Y.; Hatakeyama, H.; Sueoka, K.; Tanaka, M.; Goto, Y.I. Low dose resveratrol ameliorates mitochondrial respiratory dysfunction and enhances cellular reprogramming. Mitochondrion 2017, 34, 43–48. [Google Scholar] [CrossRef] [PubMed]
  143. Zhang, H.; Li, X.; Fan, W.; Pandovski, S.; Tian, Y.; Dillin, A. Inter-tissue communication of mitochondrial stress and metabolic health. Life Metab. 2023, 2, load001. [Google Scholar] [CrossRef] [PubMed]
  144. Nargund, A.M.; Pellegrino, M.W.; Fiorese, C.J.; Baker, B.M.; Haynes, C.M. Mitochondrial Import Efficiency of ATFS-1 Regulates Mitochondrial UPR Activation. Science 2012, 337, 587–590. [Google Scholar] [CrossRef] [PubMed]
  145. Zhang, Q.; Wu, X.Y.; Chen, P.; Liu, L.M.; Xin, N.; Tian, Y.; Dillin, A. The Mitochondrial Unfolded Protein Response Is Mediated Cell-Non-autonomously by Retromer-Dependent Wnt Signaling. Cell 2018, 174, 870–883.e17. [Google Scholar] [CrossRef]
  146. Suárez-Rivero, J.M.; Pastor-Maldonado, C.J.; Romero-González, A.; Gómez-Fernandez, D.; Povea-Cabello, S.; Alvarez-Córdoba, M.; Villalón-García, I.; Talaverón-Rey, M.; Suárez-Carrillo, A.; Munuera-Cabeza, M.; et al. Pterostilbene in Combination with Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases. Front. Pharmacol. 2022, 13, 862085. [Google Scholar] [CrossRef]
  147. Jardim, F.R.; de Rossi, F.T.; Nascimento, M.X.; Barros, R.G.D.; Borges, P.A.; Prescilio, I.C.; de Oliveira, M.R. Resveratrol and Brain Mitochondria: A Review. Mol. Neurobiol. 2018, 55, 2085–2101. [Google Scholar] [CrossRef] [PubMed]
  148. Choi, Y.; Seo, H.; Cho, M.; Kim, J.; Chung, H.S.; Lee, I.; Kim, M.J. Rutin inhibits DRP1-mediated mitochondrial fission and prevents ethanol-induced hepatotoxicity in HepG2 cells and zebrafish. Anim. Cells Syst. 2021, 25, 74–81. [Google Scholar] [CrossRef]
  149. Zhang, W.Q.; Qu, J.; Liu, G.H.; Belmonte, J.C.I. The ageing epigenome and its rejuvenation. Nat. Rev. Mol. Cell Bio 2020, 21, 137–150. [Google Scholar] [CrossRef]
  150. Sen, P.; Shah, P.P.; Nativio, R.; Berger, S.L. Epigenetic Mechanisms of Longevity and Aging. Cell 2016, 166, 822–839. [Google Scholar] [CrossRef] [PubMed]
  151. Yang, J.H.; Hayano, M.; Griffin, P.T.; Amorim, J.A.; Bonkowski, M.S.; Apostolides, J.K.; Salfati, E.L.; Blanchette, M.; Munding, E.M.; Bhakta, M.; et al. Loss of epigenetic information as a cause of mammalian aging. Cell 2023, 186, 305–326. [Google Scholar] [CrossRef] [PubMed]
  152. Lowe, R.; Barton, C.; Jenkins, C.A.; Ernst, C.; Forman, O.; Fernandez-Twinn, D.S.; Bock, C.; Rossiter, S.J.; Faulkes, C.G.; Ozanne, S.E.; et al. Ageing-associated DNA methylation dynamics are a molecular readout of lifespan variation among mammalian species. Genome Biol. 2018, 19, 22. [Google Scholar] [CrossRef] [PubMed]
  153. Weng, Y.P.; Hung, P.F.; Ku, W.Y.; Chang, C.Y.; Wu, B.H.; Wu, M.H.; Yao, J.Y.; Yang, J.R.; Lee, C.H. The inhibitory activity of gallic acid against DNA methylation: Application of gallic acid on epigenetic therapy of human cancers. Oncotarget 2018, 9, 361–374. [Google Scholar] [CrossRef] [PubMed]
  154. Griñán-Ferré, C.; Bellver-Sanchis, A.; Izquierdo, V.; Corpas, R.; Roig-Soriano, J.; Chillón, M.; Andres-Lacueva, C.; Somogyvári, M.; Soti, C.; Sanfeliu, C.; et al. The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: From antioxidant to epigenetic therapy. Ageing Res. Rev. 2021, 67, 101271. [Google Scholar] [CrossRef] [PubMed]
  155. Cione, E.; La Torre, C.; Cannataro, R.; Caroleo, M.C.; Plastina, P.; Gallelli, L. Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation. Molecules 2020, 25, 63. [Google Scholar] [CrossRef] [PubMed]
  156. Lv, M.L.; Yang, S.Y.; Cai, L.L.; Qin, L.Q.; Li, B.Y.; Wan, Z.X. Effects of Quercetin Intervention on Cognition Function in APP/PS1 Mice was Affected by Vitamin D Status. Mol. Nutr. Food Res. 2018, 62, 1800621. [Google Scholar] [CrossRef]
  157. Boesch-Saadatmandi, C.; Wagner, A.E.; Wolffram, S.; Rimbach, G. Effect of quercetin on inflammatory gene expression in mice liver—role of redox factor 1, miRNA-122 and miRNA-125b. Pharmacol. Res. 2012, 65, 523–530. [Google Scholar] [CrossRef]
  158. Zhang, X.; Abels, E.R.; Redzic, J.S.; Margulis, J.; Finkbeiner, S.; Breakefield, X.O. Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington’s Disease: Background and Evaluation in Cell Culture. Cell Mol. Neurobiol. 2016, 36, 459–470. [Google Scholar] [CrossRef]
  159. Levine, B.; Kroemer, G. Biological Functions of Autophagy Genes: A Disease Perspective. Cell 2019, 176, 11–42. [Google Scholar] [CrossRef]
  160. Wang, L.M.; Klionsky, D.J.; Shen, H.M. The emerging mechanisms and functions of microautophagy. Nat. Rev. Mol. Cell Bio 2023, 24, 186–203. [Google Scholar] [CrossRef] [PubMed]
  161. Fang, M.; Liu, Y.; Huang, C.; Fan, S.J. Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders. Biofactors 2024, 50, 422–438. [Google Scholar] [CrossRef]
  162. Rusmini, P.; Cortese, K.; Crippa, V.; Cristofani, R.; Cicardi, M.E.; Ferrari, V.; Vezzoli, G.; Tedesco, B.; Meroni, M.; Messi, E.; et al. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy 2019, 15, 631–651. [Google Scholar] [CrossRef] [PubMed]
  163. Henderson, M.X.; Trojanowski, J.Q.; Lee, V.M.Y. α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies. Neurosci. Lett. 2019, 709, 134316. [Google Scholar] [CrossRef] [PubMed]
  164. Chakraborty, J.; Pakrashi, S.; Sarbajna, A.; Dutta, M.; Bandyopadhyay, J. Quercetin Attenuates Copper-Induced Apoptotic Cell Death and Endoplasmic Reticulum Stress in SH-SY5Y Cells by Autophagic Modulation. Biol. Trace Elem. Res. 2022, 200, 5022–5041. [Google Scholar] [CrossRef]
  165. Long, J.M.; Holtzman, D.M. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell 2019, 179, 312–339. [Google Scholar] [CrossRef]
  166. Xiong, R.; Zhou, X.G.; Tang, Y.; Wu, J.M.; Sun, Y.S.; Teng, J.F.; Pan, R.; Law, B.Y.; Zhao, Y.; Qiu, W.Q.; et al. Lychee seed polyphenol protects the blood-brain barrier through inhibiting Abeta(25–35)-induced NLRP3 inflammasome activation via the AMPK/mTOR/ULK1-mediated autophagy in bEnd.3 cells and APP/PS1 mice. Phytother. Res. 2021, 35, 954–973. [Google Scholar] [CrossRef]
  167. Holczer, M.; Besze, B.; Zambo, V.; Csala, M.; Banhegyi, G.; Kapuy, O. Epigallocatechin-3-Gallate (EGCG) Promotes Autophagy-Dependent Survival via Influencing the Balance of mTOR-AMPK Pathways upon Endoplasmic Reticulum Stress. Oxid. Med. Cell Longev. 2018, 2018, 6721530. [Google Scholar] [CrossRef]
  168. Pineda-Ramirez, N.; Aguilera, P. Resveratrol as an inductor of autophagy: Is there a unique pathway of activation? Neural Regen. Res. 2021, 16, 101–103. [Google Scholar] [CrossRef]
  169. Ruetenik, A.; Barrientos, A. Dietary restriction, mitochondrial function and aging: From yeast to humans. Biochim. Biophys. Acta 2015, 1847, 1434–1447. [Google Scholar] [CrossRef]
  170. Hwangbo, D.S.; Lee, H.Y.; Abozaid, L.S.; Min, K.J. Mechanisms of Lifespan Regulation by Calorie Restriction and Intermittent Fasting in Model Organisms. Nutrients 2020, 12, 1194. [Google Scholar] [CrossRef]
  171. Waziry, R.; Ryan, C.P.; Corcoran, D.L.; Huffman, K.M.; Kobor, M.S.; Kothari, M.; Graf, G.H.; Kraus, V.B.; Kraus, W.E.; Lin, D.T.S.; et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nat. Aging 2023, 3, 248–257. [Google Scholar] [CrossRef] [PubMed]
  172. Carroll, B.; Korolchuk, V.I. Nutrient sensing, growth and senescence. FEBS J. 2018, 285, 1948–1958. [Google Scholar] [CrossRef] [PubMed]
  173. Spadaro, O.; Youm, Y.; Shchukina, I.; Ryu, S.; Sidorov, S.; Ravussin, A.; Nguyen, K.; Aladyeva, E.; Predeus, A.N.; Smith, S.R.; et al. Caloric restriction in humans reveals immunometabolic regulators of health span. Science 2022, 375, 671–677. [Google Scholar] [CrossRef]
  174. Timmers, S.; Konings, E.; Bilet, L.; Houtkooper, R.H.; van de Weijer, T.; Goossens, G.H.; Hoeks, J.; van der Krieken, S.; Ryu, D.; Kersten, S.; et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011, 14, 612–622. [Google Scholar] [CrossRef]
  175. Furman, D.; Campisi, J.; Verdin, E.; Carrera-Bastos, P.; Targ, S.; Franceschi, C.; Ferrucci, L.; Gilroy, D.W.; Fasano, A.; Miller, G.W.; et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 2019, 25, 1822–1832. [Google Scholar] [CrossRef] [PubMed]
  176. Li, X.; Li, C.; Zhang, W.; Wang, Y.; Qian, P.; Huang, H. Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduct. Target. Ther. 2023, 8, 239. [Google Scholar] [CrossRef] [PubMed]
  177. Ansari, M.Y.; Ahmad, N.; Haqqi, T.M. Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols. Biomed. Pharmacother. 2020, 129, 110452. [Google Scholar] [CrossRef]
  178. Kocaadam, B.; Sanlier, N. Curcumin, an active component of turmeric, and its effects on health. Crit. Rev. Food Sci. 2017, 57, 2889–2895. [Google Scholar] [CrossRef]
  179. Chen, P.; Chen, F.C.; Lei, J.X.; Zhou, B.H. Pomegranate polyphenol punicalagin improves learning memory deficits, redox homeostasis, and neuroinflammation in aging mice. Phytother. Res. 2023, 37, 3655–3674. [Google Scholar] [CrossRef]
  180. Angele-Martinez, C.; Ameer, F.S.; Raval, Y.S.; Huang, G.; Tzeng, T.J.; Anker, J.N.; Brumaghim, J.L. Polyphenol effects on CuO-nanoparticle-mediated DNA damage, reactive oxygen species generation, and fibroblast cell death. Toxicol. In Vitro 2022, 78, 105252. [Google Scholar] [CrossRef]
  181. Dobrzynska, M.M.; Gajowik, A. Protection and Mitigation by Resveratrol of DNA Damage Induced in Irradiated Human Lymphocytes In Vitro. Radiat. Res. 2022, 197, 149–156. [Google Scholar] [CrossRef] [PubMed]
  182. Priya, B.; Ravi, S.; Kirubakaran, S. Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic. Drug Discov. Today 2023, 28, 103662. [Google Scholar] [CrossRef]
  183. Thilakarathna, W.; Rupasinghe, H.P.V. Microbial metabolites of proanthocyanidins reduce chemical carcinogen-induced DNA damage in human lung epithelial and fetal hepatic cells in vitro. Food Chem. Toxicol. 2019, 125, 479–493. [Google Scholar] [CrossRef]
  184. Zeng, X.; Li, X.; Li, X.; Wei, C.; Shi, C.; Hu, K.; Kong, D.; Luo, Q.; Xu, Y.; Shan, W.; et al. Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation. Blood 2023, 141, 1691–1707. [Google Scholar] [CrossRef]
  185. Parker, A.; Romano, S.; Ansorge, R.; Aboelnour, A.; Le Gall, G.; Savva, G.M.; Pontifex, M.G.; Telatin, A.; Baker, D.; Jones, E.; et al. Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain. Microbiome 2022, 10, 68. [Google Scholar] [CrossRef]
  186. Barcena, C.; Valdes-Mas, R.; Mayoral, P.; Garabaya, C.; Durand, S.; Rodriguez, F.; Fernandez-Garcia, M.T.; Salazar, N.; Nogacka, A.M.; Garatachea, N.; et al. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nat. Med. 2019, 25, 1234–1242. [Google Scholar] [CrossRef]
  187. Chen, L.; Zhernakova, D.V.; Kurilshikov, A.; Andreu-Sanchez, S.; Wang, D.; Augustijn, H.E.; Vich Vila, A.; Lifelines Cohort, S.; Weersma, R.K.; Medema, M.H.; et al. Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. Nat. Med. 2022, 28, 2333–2343. [Google Scholar] [CrossRef]
  188. Mou, Y.; Du, Y.; Zhou, L.; Yue, J.; Hu, X.; Liu, Y.; Chen, S.; Lin, X.; Zhang, G.; Xiao, H.; et al. Gut Microbiota Interact with the Brain through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging. Front. Immunol. 2022, 13, 796288. [Google Scholar] [CrossRef]
  189. Cryan, J.F.; O’Riordan, K.J.; Cowan, C.S.M.; Sandhu, K.V.; Bastiaanssen, T.F.S.; Boehme, M.; Codagnone, M.G.; Cussotto, S.; Fulling, C.; Golubeva, A.V.; et al. The Microbiota-Gut-Brain Axis. Physiol. Rev. 2019, 99, 1877–2013. [Google Scholar] [CrossRef] [PubMed]
  190. Ghosh, T.S.; Rampelli, S.; Jeffery, I.B.; Santoro, A.; Neto, M.; Capri, M.; Giampieri, E.; Jennings, A.; Candela, M.; Turroni, S.; et al. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: The NU-AGE 1-year dietary intervention across five European countries. Gut 2020, 69, 1218–1228. [Google Scholar] [CrossRef] [PubMed]
  191. Sharma, R.; Kumar, R.; Sharma, A.; Goel, A.; Padwad, Y. Long-term consumption of green tea EGCG enhances murine health span by mitigating multiple aspects of cellular senescence in mitotic and post-mitotic tissues, gut dysbiosis, and immunosenescence. J. Nutr. Biochem. 2022, 107, 109068. [Google Scholar] [CrossRef] [PubMed]
  192. Wei, R.; Su, Z.; Mackenzie, G.G. Chlorogenic acid combined with epigallocatechin-3-gallate mitigates D-galactose-induced gut aging in mice. Food Funct. 2023, 14, 2684–2697. [Google Scholar] [CrossRef] [PubMed]
  193. Wu, W.; Wu, X.; Qiu, L.; Wan, R.; Zhu, X.; Chen, S.; Yang, X.; Liu, X.; Wu, J. Quercetin influences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis. Naunyn Schmiedebergs Arch. Pharmacol. 2024, 397, 4809–4822. [Google Scholar] [CrossRef]
  194. Yan, C.J.; Zhou, Z. Ellagic acid and pentagalloylglucose are potential inhibitors of prion protein fibrillization. Int. J. Biol. Macromol. 2021, 172, 371–380. [Google Scholar] [CrossRef]
Figure 1. The anti-aging effects of polyphenols on different organs and tissues. Polyphenols have significant biological effects on different tissues and organs as indicated by in vivo preclinical studies and clinical trial data. They boost physiological functions that decline with age and lower the occurrence of age-associated pathologies. Upward arrows stand for up-regulation. Downward arrows stand for down-regulation.
Figure 1. The anti-aging effects of polyphenols on different organs and tissues. Polyphenols have significant biological effects on different tissues and organs as indicated by in vivo preclinical studies and clinical trial data. They boost physiological functions that decline with age and lower the occurrence of age-associated pathologies. Upward arrows stand for up-regulation. Downward arrows stand for down-regulation.
Nutrients 16 03305 g001
Figure 2. Polyphenols exhibit anti-aging effects as senolytics, mitochondrial protectors, anti-inflammatory agents, calorie restriction mimics, autophagy inducers, and antioxidants. (a) Cellular senescence and senolytics. (b) Mitochondrial dysfunction and mitochondrial protector. (c) Chronic inflammation and anti-inflammatory polyphenols. (d) Dysregulated nutrient-sensing and calorie restriction mimics. (e) Disabled macroautophagy and autophagy inducer. (f) Genomic instability and antioxidants. Red arrows stand for down-regulation. Green arrows stand for up-regulation. Abbreviations: AKT, protein kinase B; AP-1, activator protein 1; ATG12, autophagy-related 12; ATG5, autophagy-related 5; ATG7, autophagy-related 7; ARE, antioxidant response element; ATM, ataxia telangiectasia mutated; Bak, Bcl-2 homologous antagonist/killer; Bax, Bcl-2-associated X protein; Bcl-2, B-cell lymphoma 2; CCL-2, C-C motif chemokine ligand 2; CAT, catalase; Cy3G, cyanidin 3-glucoside; DNMT, DNA methyltransferase; DRP1, dynamin-related protein 1; EA, ellagic acid; EGCG, epigallocatechin-3-gallate; FOXO4, fork head box O transcription factor 4; FOXO4-DRI, fork head box O transcription factor 4-D-retro-inverso; GA, gallic acid; GCLC, glutamate-cysteine ligase catalytic subunit; GST, glutathione S-transferase; HAT, histone acetyltransferase; HDAC, histone deacetylase; HDM, histone demethylase; HMOX1, heme oxygenase 1; IGF-1, insulin-like growth factor 1; IL-1, interleukin-1; IL-18, interleukin-18; IL-3, interleukin-3; IL-6, interleukin-6; IL-8, interleukin-8; Keap1, Kelch-like ECH-associated protein 1; LC3, microtubule-associated protein 1 light chain 3; MAPK, mitogen-activated protein kinase; MFN1, mitofusin 1; MFN2, mitofusin 2; NDGA, nordihydroguaiaretic acid; NF-κB, nuclear factor kappa-B; NAD+, nicotinamide adenine dinucleotide; NADH, nicotinamide adenine dinucleotide hydrogen; NADPH, nicotinamide adenine dinucleotide phosphate; Nrf2, nuclear factor erythroid 2-related factor 2; OPA1, optic atrophy 1; OXPHOS, oxidative phosphorylation; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; PI3K, phosphatidylinositol 3-kinase; PCC1, procyanidin C1; PTS, pterostilbene; ROS, reactive oxygen species; SASP, senescence-associated secretory phenotype; SIRT1, sirtuin 1; SOD, superoxide dismutase; TGF-β, transforming growth factor-beta; TERC, telomerase RNA component; TERT, telomerase reverse transcriptase; TNF-α, tumor necrosis factor-alpha; UPRmt, mitochondrial unfolded protein response; mTOR, mammalian target of rapamycin.
Figure 2. Polyphenols exhibit anti-aging effects as senolytics, mitochondrial protectors, anti-inflammatory agents, calorie restriction mimics, autophagy inducers, and antioxidants. (a) Cellular senescence and senolytics. (b) Mitochondrial dysfunction and mitochondrial protector. (c) Chronic inflammation and anti-inflammatory polyphenols. (d) Dysregulated nutrient-sensing and calorie restriction mimics. (e) Disabled macroautophagy and autophagy inducer. (f) Genomic instability and antioxidants. Red arrows stand for down-regulation. Green arrows stand for up-regulation. Abbreviations: AKT, protein kinase B; AP-1, activator protein 1; ATG12, autophagy-related 12; ATG5, autophagy-related 5; ATG7, autophagy-related 7; ARE, antioxidant response element; ATM, ataxia telangiectasia mutated; Bak, Bcl-2 homologous antagonist/killer; Bax, Bcl-2-associated X protein; Bcl-2, B-cell lymphoma 2; CCL-2, C-C motif chemokine ligand 2; CAT, catalase; Cy3G, cyanidin 3-glucoside; DNMT, DNA methyltransferase; DRP1, dynamin-related protein 1; EA, ellagic acid; EGCG, epigallocatechin-3-gallate; FOXO4, fork head box O transcription factor 4; FOXO4-DRI, fork head box O transcription factor 4-D-retro-inverso; GA, gallic acid; GCLC, glutamate-cysteine ligase catalytic subunit; GST, glutathione S-transferase; HAT, histone acetyltransferase; HDAC, histone deacetylase; HDM, histone demethylase; HMOX1, heme oxygenase 1; IGF-1, insulin-like growth factor 1; IL-1, interleukin-1; IL-18, interleukin-18; IL-3, interleukin-3; IL-6, interleukin-6; IL-8, interleukin-8; Keap1, Kelch-like ECH-associated protein 1; LC3, microtubule-associated protein 1 light chain 3; MAPK, mitogen-activated protein kinase; MFN1, mitofusin 1; MFN2, mitofusin 2; NDGA, nordihydroguaiaretic acid; NF-κB, nuclear factor kappa-B; NAD+, nicotinamide adenine dinucleotide; NADH, nicotinamide adenine dinucleotide hydrogen; NADPH, nicotinamide adenine dinucleotide phosphate; Nrf2, nuclear factor erythroid 2-related factor 2; OPA1, optic atrophy 1; OXPHOS, oxidative phosphorylation; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; PI3K, phosphatidylinositol 3-kinase; PCC1, procyanidin C1; PTS, pterostilbene; ROS, reactive oxygen species; SASP, senescence-associated secretory phenotype; SIRT1, sirtuin 1; SOD, superoxide dismutase; TGF-β, transforming growth factor-beta; TERC, telomerase RNA component; TERT, telomerase reverse transcriptase; TNF-α, tumor necrosis factor-alpha; UPRmt, mitochondrial unfolded protein response; mTOR, mammalian target of rapamycin.
Nutrients 16 03305 g002
Figure 3. The role of anti-aging treatments, including polyphenols in the 12 hallmarks of aging. Explanation: Quercetin* itself is a natural polyphenolic compound. However, the senolytic drug combination group “quercetin + dasatinib” is more worthy of attention due to its anti-aging effect. Therefore, quercetin in this table refers to this drug combination group. NMN was originally a dietary supplement but has now been withdrawn by the FDA. GLP-1RA* refers to GLP-1 receptor agonists, widely used in obesity and diabetes. The latest research evidence indicates that it has potential anti-aging effects. “With clinical trials” means that there are clinical trial records of the compound on the official clinical trials website. “Approved by FDA for medication” means whether the FDA has approved this compound as a drug. “Approved by FDA for supplement” means whether the FDA has approved this compound as a dietary supplement. “Compound involvement in the hallmarks” and “role in aging phenotype” mainly refer to whether the polyphenol inhibits the 12 hallmarks or regulates the hallmarks to have a beneficial effect on aging experimentally (or in laboratory studies) before clinical trials (https://clinicaltrials.gov/) (accessed on 17 September 2024).
Figure 3. The role of anti-aging treatments, including polyphenols in the 12 hallmarks of aging. Explanation: Quercetin* itself is a natural polyphenolic compound. However, the senolytic drug combination group “quercetin + dasatinib” is more worthy of attention due to its anti-aging effect. Therefore, quercetin in this table refers to this drug combination group. NMN was originally a dietary supplement but has now been withdrawn by the FDA. GLP-1RA* refers to GLP-1 receptor agonists, widely used in obesity and diabetes. The latest research evidence indicates that it has potential anti-aging effects. “With clinical trials” means that there are clinical trial records of the compound on the official clinical trials website. “Approved by FDA for medication” means whether the FDA has approved this compound as a drug. “Approved by FDA for supplement” means whether the FDA has approved this compound as a dietary supplement. “Compound involvement in the hallmarks” and “role in aging phenotype” mainly refer to whether the polyphenol inhibits the 12 hallmarks or regulates the hallmarks to have a beneficial effect on aging experimentally (or in laboratory studies) before clinical trials (https://clinicaltrials.gov/) (accessed on 17 September 2024).
Nutrients 16 03305 g003
Table 1. Dietary anti-aging polyphenols and potential mechanisms.
Table 1. Dietary anti-aging polyphenols and potential mechanisms.
PolyphenolsSourceAge-Related ConditionsModelDosageAnti-Aging Activity and Proposed Anti-Aging Mechanism
Resveratrol
Nutrients 16 03305 i001
Grapes, red wine, peanuts, and blueberriesAge-related motor deficitsOlder adults500 mg/day, 1000 mg/dayA pilot randomized controlled trial indicates that the combined application of exercise training and resveratrol in elderly people with functional limitations could improve skeletal muscle mitochondrial function and exercise-related physical function indicators [58].
Sarcopenic obesitySprague-Dawley (SD) rats0.4% of dietResveratrol could ameliorate mitochondrial dysfunction and oxidative stress, thereby improving protein metabolism and helping to prevent sarcopenic obesity in the elderly [59].
AgingddY mice (derived from a non-inbred strain carrying a retrovirus causing significant mortality with age)0.4 g/kg of dietResveratrol could reduce the level of acetylated proteins in muscles and restore autophagic activity, thereby alleviating age-related sarcopenia and cardiomyocyte hypertrophy [60].
AgingHtrA2 KO mice (the absence of serine/threonine protease HtrA2 causes a PD phenotype)25 mg/kg body weight (BW)Resveratrol treatment can extend the lifespan of HtrA2 KO mice and delay the deterioration of the motor phenotype by attenuating apoptosis at the level of Bax [61].
AgingCaenorhabditis elegans (C. elegans)100 mMResveratrol, as a Sirtuin activator, can simulate calorie restriction and extend the lifespan of C. elegans [62].
AgingDrosophila melanogaster200 μMSupplementation of resveratrol to larval can effectively eliminate ROS, thereby extending the adult lifespan of fruit flies and not reducing their reproductive capacity [63].
Ovarian agingN. guentheri200 μg/g foodResveratrol could delay ovarian aging by alleviating inflammation and ER stress through the SIRT1/NRF2 pathway [64].
AgingS. cerevisiae10, 100, 500 μMResveratrol could mimic calorie restriction by stimulating Sir2, increase DNA stability, and extend lifespan by 70% in yeast [65].
AgingHuman mononuclear cells (PBMCs)5 µMCompared with the elderly, resveratrol exerts better antioxidant and anti-inflammatory effects in PBMCs of middle-aged individuals [66].
Brain agingHippocampal astrocytes10 μMResveratrol could increase the antioxidant defense capacity and reduce pro-inflammatory cytokines in hippocampal astrocyte cultures of rats of all ages, improving NDs [67].
Age-related motor deficitsSH-SY5Y cells1 or 5 μMResveratrol alleviates age-related motor deficits by promoting the survival of dopaminergic neurons and the activation of the ERK1/2 pathway [68].
Ellagic acid
Nutrients 16 03305 i002
Berries, nuts, tea, and medicinal plants [69]AgingD-gal-induced aging rats120 mg/kg BWEA improved oxidative damage and inflammation in D-gal-induced aging rats [70].
Hepatic lipid metabolism disorders induced by aging25-month-old rats30 mg/kg BW EA affected lipid metabolism in the aged liver via the sirt1/AMPK/sreBP-1c/PPAr-α pathway for age-related metabolic disorders [71].
Brain agingSD rats10, 30, 90 mg/kg BWEA could increase the proliferation of brain neural stem cells and protect brain cell activity through the Wnt/β-catenin signaling pathway to help treat nerve dysfunction, NDs, and aging [72].
OsteoporosisC57BL/6 mice, bone mesenchymal stem cellsMice: 10, 50 mg/kg BW; cell: 0 μM–30 μMEA could promote bone formation by activating the SMAD2/3 signaling pathway to ameliorate aging-induced osteoporosis [73].
Skin agingMale SKH-1 hairless mice, human dermal fibroblastsMice: 10 μmol/L, cell: 1–10 μmol/LEA could reduce wrinkles and UV-induced skin inflammation to improve photoaging by decreasing UV-B-induced collagen degradation and inflammatory reactions [74].
AgingC. elegans50 μMEA reduced the injury caused by UV radiation and enhanced stress resistance to extend the lifespan of C. elegans [75].
AgingDrosophila melanogaster100 μM and 200 μMEA can up-regulate the expression of dFOXO, CAT, and SOD, thereby extending lifespan [76].
AgingSH-SY5Y cells0.1–1 μMLower concentrations of EA could provide better anti-aging benefits than higher concentrations of EA and metformin, presumably via the PPAR-γ/ HO-1 signaling pathway [77].
Skin sagging and wrinklingHuman dermal fibroblasts2 μg/mLEA improved skin extracellular matrix production of elastin and collagen and improved skin fine wrinkles [78].
Urolithin A
Nutrients 16 03305 i003
Gut microbiota metabolite of EAAgingHealthy elderly male and female250, 500, 1000 and 2000 mg UA could promote mitochondrial autophagy and improve muscle health in old animals and in preclinical models of aging [79].
AgingD-gal-induced aging mice3, 15 mg/kg BWUro-A from the colon can prevent D-gal-induced aging in mice by blocking NF-κB and mTOR targets, improving motor and cognitive abilities [80].
Alzheimer’s disease (AD)3xTg-AD mice, B6129SF2/J mice5 mg/kg BWUA could improve the cognition of 3xTg-AD mice and prolong longevity in normal aging mice by inducing autophagy and increasing amyloid-β (Aβ) clearance in neuronal cells [81].
AgingC. elegans, C57BL/6 miceC. elegans: 50 μM, mice: 50 mg/kg BWUrolithin A could induce mitophagy and improve mitochondrial and muscle function in C. elegans and rodents, leading to life extension [82].
Brain agingH2O2-induced PC12 cell, D-gal-induced aging miceCell: 10, 30, 50 μg/mL, Mice: 50, 100, 150 mg/kg body weightUrolithin A can exert neuroprotective effects and delay brain aging by activating miR-34a-mediated SIRT1/mTOR signaling pathway [83].
AgingD-gal-induced aging mice50, 100, 150 mg/kg BWUA could attenuate D-gal-induced liver injury in aged mice via antioxidant, anti-inflammatory, and anti-apoptotic properties [84].
Gallic acid
Nutrients 16 03305 i004
Rheum palmatum, Eucalyptus robusta, Cornus officinalisAge-associated thymic involutionD-gal-treated mice 200, 250, 500 mg/kg body weightGA administration may ameliorate age-related thymic degeneration and enhance immune function in the elderly by stimulating FoxN1 expression, increasing proliferating cells, and decreasing apoptotic cells [85].
AgingH2O2-induced rat’s embryonic fibroblast cells1000 μMGA could postpone aging through its antioxidative stress potential and modulation of mitochondrial complexes’ activities [86].
ADAPP/PS1 transgenic AD mouse model20 mg/kg body weightEA could inhibit neuroinflammation and stabilize brain oxidative stress [87].
Rutin
Nutrients 16 03305 i005
Fagopyrum esculentum, Ruta graveolens, and Sophora japonica [88]AgingDrosophila melanogaster200 μM and 400 μMRutin could improve the resistance of male and female Drosophila melanogaster fed with a high-fat diet, increase the expression of age-related genes, and extend longevity [89].
Huntington’s diseaseC. elegans15, 30, 60, 120 μMRutin could inhibit polyglutamine protein aggregation in muscle, decrease neuronal death, and extend longevity through antioxidant, autophagy, and insulin/IGF1 signaling pathways [90].
AgingD-gal-treated mice50 mg/kg body weightRutin could enhance the biochemical indicators of aging rats by exerting antioxidant effects and regulating apoptosis-related proteins to inhibit cell apoptosis [91].
Age-related metabolic dysfunctionTwenty-month-old rats25, 50 mg/kg body weightRutin suppresses aging-associated mitochondrial dysfunction, endoplasmic reticulum stress, and oxidative stress, thus improving the response to age-related metabolic dysfunction [92].
ADTgAPP mice (a model for AD)30 mg/kg body weightRutin could raise GSH/GSSG levels, reduce MDA levels, and inhibit APP expression and BACE1 activity, resulting in anti-AD and anti-aging benefits [93].
Quercetin
Nutrients 16 03305 i006
Grapes, peaches, onions, garlic [94]Age-related metabolic dysfunctionTwenty-one-month-old miceDasatinib (5 mg/kg BW) and quercetin (50 mg/kg BW)Dasatinib + quercetin (D + Q) lowers inflammation in adipose tissue and enhances systemic metabolic function in older people [95].
Age-dependent progression of disc degenerationC57BL/6 miceDasatinib (5 mg/kg BW) and quercetin (50 mg/kg BW)D + Q can target senescent cells non-invasively and lessen the impact of age-dependent degeneration [96].
AgingMacaca fascicularisDasatinib (5 mg/kg BW) and quercetin (50 mg/kg BW)D + Q could prevent aging by strengthening the gut barrier, boosting immunity, and combating inflammation [97].
AgingC57BL/6 miceDasatinib (5 mg/kg BW) and quercetin (50 mg/kg BW)D + Q could lead to selective elimination of senescent cells and the release of senescence-associated pro-inflammatory cytokines [98].
Intestinal senescenceBALB/c miceDasatinib (5 mg/kg BW) and quercetin (50 mg/kg BW)Long-term D + Q treatment could decrease the gene expression of senescence and inflammation to alleviate intestinal senescence [9].
Naringenin
Nutrients 16 03305 i007
Ribes meyeriAgingC57BL/6 mice25, 50, 100 mg/kg BWNaringenin could reduce neuronal damage and mitigate systemic inflammation induced by LPS by modulating the expression of NF-κB/TNFα/COX-2/iNOS/TLR4/GFAP [99].
Retinal degenerationC57BL/6 mice100 mg/kg BWOral administration of naringenin could regulate mitochondrial dynamics and autophagy to counteract aging-related retinal degeneration [100].
AgingC. elegans, 6-month-old C57BL/6J miceC. elegans: 100 μM, mice: 100 mg/kg BWNaringenin could extend the lifespan of C. elegans and slow brain aging in mice by increasing the expression of SIRT enzymes, promoting the activity of metabolic enzymes, and upregulating the expression of anti-aging markers [101].
Cyanidin-3-O-glucoside (Cy3G)
Nutrients 16 03305 i008
Vegetables and berries [102]ADHMC3 cell, APPswe/PS1ΔE9 mice (a model for AD)cell: 50 μM, mice: 30 mg/kg BWCy3G could eliminate accumulated β-amyloid and modulate microglial polarization by activating PPARγ and promoting Aβ42 phagocytosis through TREM2 overexpression [103].
ADAPPswe/PS1ΔE9 mice30 mg/kg BWCy3G could reduce lysosome-associated protein expression, increase autophagy, and modulate the PI3K/Akt/GSK3β signaling pathway to protect neurons and enhance cognitive performance in AD mice [104].
ADSD rats received Aβ in the hippocampus10 mg/kg BWCy3G could attenuate Aβ-induced tau protein hyperphosphorylation and GSK-3β hyperactivation, possibly rescuing Aβ-induced cognitive deficits through GSK-3β/tau variation [105].
ADAPPswe/PS1ΔE9 mice30 mg/kg BWCy3G may exert therapeutic effects on AD through antioxidant and immunomodulatory mechanisms [106].
Parkinson’s disease (PD)MPTP-induced C57BL/6J10, 20, 40 mg/kg BWCy3G could play a role in the treatment of PD by modulating the structure and metabolism of gut microbiota [107].
AgingC. elegans12.5, 25, 50 μg/mLCy3G could enhance resistance and extend the lifespan of polystyrene-exposed C. elegans through the DAF-16 pathway [108].
AgingH9c2 cells1 mMCy3G could decrease CD38 expression, increase Sirt6 expression in tissues, and restore NAD+ and NK cell levels to exert anti-aging effects through CD38-Sirt6 signaling [109].
Procyanidin C1 (PCC1)
Nutrients 16 03305 i009
Grape seed extractAgingPSC27 cells, WI38 cells, HUVEC cells; C57BL/6J miceCell: 1, 5, 10 μg/mL
Mice: 20 mg/kg BW
Low concentrations of PCC1 can inhibit the formation of SASP, while at higher concentrations, it may selectively kill senescent cells by promoting the production of ROS and mitochondrial dysfunction [110].
Aged retinaAged mice8 mg/kg of dietLong-term PCC1 treatment could relieve function and structural impairment in the aged retina and reduce the accumulation of senescent cells and secretion of SASP [111].
Nordihydroguaiaretic acid
Nutrients 16 03305 i010
Larrea tridentataAgingUM-HET3 mice (designed to model the aging process and age-related diseases)2.5, 5 g/kg of dietNordihydroguaiaretic acid could increase the survival rate of male mice but does not change the survival rate of female mice, which might be explained by gender differences in steady-state levels or drug metabolism [112].
Pterostilbene
Nutrients 16 03305 i011
BlueberriesADSenescence accelerated mouse prone 8 (SAMP8) mice120 mg/kg of dietPterostilbene could increase the expression of peroxisome proliferator-activated receptor (PPAR) α, improve cognitive function and cellular stress regulation ability, and alleviate AD symptoms [113].
AD18-month-old rats22.5 mg/kg BW Pterostilbene could increase the expression of postsynaptic density protein 95 and improve the cognitive ability of elderly rats with mild cognitive impairment AD [114].
AD19-month-old male Fischer40, 160 mg/kg of dietPterostilbene can effectively reverse cognitive behavioral deficits and dopamine release and improve age-related cognitive degeneration [115].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Liu, Y.; Fang, M.; Tu, X.; Mo, X.; Zhang, L.; Yang, B.; Wang, F.; Kim, Y.-B.; Huang, C.; Chen, L.; et al. Dietary Polyphenols as Anti-Aging Agents: Targeting the Hallmarks of Aging. Nutrients 2024, 16, 3305. https://doi.org/10.3390/nu16193305

AMA Style

Liu Y, Fang M, Tu X, Mo X, Zhang L, Yang B, Wang F, Kim Y-B, Huang C, Chen L, et al. Dietary Polyphenols as Anti-Aging Agents: Targeting the Hallmarks of Aging. Nutrients. 2024; 16(19):3305. https://doi.org/10.3390/nu16193305

Chicago/Turabian Style

Liu, Ying, Minglv Fang, Xiaohui Tu, Xueying Mo, Lu Zhang, Binrui Yang, Feijie Wang, Young-Bum Kim, Cheng Huang, Liang Chen, and et al. 2024. "Dietary Polyphenols as Anti-Aging Agents: Targeting the Hallmarks of Aging" Nutrients 16, no. 19: 3305. https://doi.org/10.3390/nu16193305

APA Style

Liu, Y., Fang, M., Tu, X., Mo, X., Zhang, L., Yang, B., Wang, F., Kim, Y. -B., Huang, C., Chen, L., & Fan, S. (2024). Dietary Polyphenols as Anti-Aging Agents: Targeting the Hallmarks of Aging. Nutrients, 16(19), 3305. https://doi.org/10.3390/nu16193305

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop